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ABSTRACT 
Background. Childhood obesity is a severe public health problem in the United States. The 
STRONG Kids Program was designed to identify risk factors for excessive weight gain and 
obesity development in preschool-age children based on the ecological framework of the six Cs’ 
model. Increased food intake, which is one of the critical factors leading to the onset of obesity 
has been strongly associated with genetic predisposition. Variations in genes involved or 
potentially related to the leptin-melanocortin pathway (i.e. BDNF, FTO, LEP, LEPR, MC4R, 
PCSK1, POMC, TUB) have been associated with symptoms of poor appetite control and obesity-
related phenotypes.  
Hypothesis. Individual genetic variations related to satiety and appetite control in the BDNF, 
FTO, LEP, LEPR, MC4R, PCSK1, POMC, and TUB genes are associated with the risk of 
obesity in preschool-age children. 
Objectives. The objectives of the current study are: (1) to investigate the association between 
obesity related phenotypes and genetic variations; (2) to investigate the association between 
genetic variations with satiety and appetite control; (3) to investigate the association between the 
obesity phenotypes and satiety and appetite control. 
Methods. Height and weight were measured in 128 Caucasian preschool children from the 
STRONG Kids Program (age 39.9 + 2.0 months, BMI 16.5 + 1.2 kg/m
2
).  Genomic DNA was 
extracted from saliva samples and used for genotyping. Eight SNPs rs925946, rs1137101, 
rs8057044, rs6235, rs934778, rs2272382, rs7799039 and rs17782313 within or near the BDNF, 
LEPR, FTO, PCSK1, POMC, TUB, LEP, MC4R genes were genotyped by either FP-TDI assay 
or TaqMan SNP genotyping assay. Statistical analyses were performed with SAS 9.2 and p-link 
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software to test the association between genotype and anthropometric data, and to calculate the 
genetic scores. 
Results. In this cohort, 25 children (19.5%) were overweight and 8 children (6.3%) were obese. 
There were significant associations between the height-for-age z-score and the rs2272382 SNP 
on TUB (P=0.0021) after adjusting for breastfeeding duration. The SNP rs17782313 in the 
MC4R gene also showed significant association with height-for-age z-score (P=0.038) before, 
but not after, adjusting for breastfeeding duration. As the number of risk allele increases, the risk 
of being obese or showing the first signs of being obese also increases. The responses to question 
seven in the survey (when this child gets fussy, is giving him/her something to eat or drink the 
first thing you do?) was significantly linked with rs925946 (P=0.0317). The responses of 
‘Restriction for Weight Control’ (cluster 11) were significantly associated with BMI (P=0.049). 
The ‘Restriction for Health’ (cluster 10) showed a borderline significant association with CDC 
weight-for-age z-score (P=0.0567).  
Conclusion. Our observation suggest that genetic variants on TUB, MC4R, BDNF and LEP are 
related to the risk of obesity in our cohort; as the number of risk alleles increases, the risk of 
early-onset obesity increases. Preliminary data showed an association between genetic variations 
and satiety and appetite control, and an association between the obesity phenotypes and satiety 
and appetite control. Further modifications of the survey and questions are still needed.  
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CHAPTER 1 
INTRODUCTION 
 
Obesity is a severe public health problem in the United States. The prevalence of obesity 
in both adult and children has been increasing steadily. According to CDC, in 2007-2008, 16.9%  
of children in the United States between 2 and 20 years were obese (at or above the 95
th 
 
percentile of BMI for age); and 31.7% Children were overweight (at or above the 85
th
 percentile 
of BMI for age). Children who were obese during childhood are more likely to carry the extra 
pounds over into the adulthood. Studies showed that that approximately 80% of children who 
were obese during childhood and adolescence were obese adults at age 25 years (1). 
Food intake, one of the critical components impacting the onset of obesity, is a complex 
trait resulting not only from physiological, psychological, and social effects but also from the 
influence of genetic predisposition. Many studies have indicated the association between eating 
behaviors, food preference and selection of proportion size with genetic variations (2-4). A study 
with adult twin pairs showed significant heritability of 65% for total energy intake (5).  
Food intake is regulated both peripherally and centrally. In the brain, the hypothalamus is 
a critical region for the regulation of food intake (6-8). It contains different neuronal populations 
or nuclei, including the arcuate nucleus (ARC), dorsomedial nucleus (DMN), lateral 
hypothalamus area (LHA), paraventricular nucleus (PVN), and ventromedial nucleus (VMN). 
Among them, ARC is considered as one of the most important nuclei in satiety and appetite 
control. The leptin-melanocortin signaling pathway is well-recognized for its critical function in 
appetite control. Individual variations in genes involved or potentially related to this pathway 
(i.e. BDNF, FTO, LEP, LEPR, MC4R, PCSK1, POMC, TUB) have been associated with 
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symptoms of poor appetite control and obesity-related phenotypes (2,9,10). In chapter 2, current 
state of the literature of childhood obesity, regulation of food intake and studies on candidate 
genes are presented. 
We hypothesize that individual genetic variations related to satiety and appetite control in 
the BDNF, FTO, LEP, LEPR, MC4R, PCSK1, POMC, and TUB genes are associated with the 
risk of obesity in preschool-age children. Two studies (chapter 3 and chapter 4) will be covered 
in this thesis. The objective of the first study (chapter 3) is to investigate the association between 
obesity related phenotypes and genetic variations. The objectives of the second study (chapter 4) 
are to investigate the association between genetic variations with satiety and appetite control, and 
to investigate the association between the obesity phenotypes and satiety and appetite control. 
Future directions upon these studies will be indicated in chapter 5.  
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CHAPTER 2 
LITERATURE REVIEW 
 
Definition and Measurement of Overweight and Obesity 
Obesity is the result of an imbalance between energy intake and energy expenditure 
resulting in the storage of energy as fat. Obesity is generally defined as an excess percentage of 
body fat. However, it is usually difficult to measure body fat directly. Therefore, obesity is often 
defined as excess body weight rather than excess body fat. The body mass index (BMI) is widely 
used as an indicator of obesity. It is calculated by weight divided by square of the height. It 
provides a way to compare body weight in terms of height. However, due to difference in body 
composition, BMI is not always an accurate indicator of body fat. People with greater muscle 
mass usually have higher BMI, although their body fat is in an acceptable range.  
Although it is only a surrogate measure of body fatness, BMI is a relatively simple 
measure and a useful tool. BMI is widely used in epidemiologic studies because, for most 
people, it parallels well to total body fat (1). Adults who have a BMI between 25 and 29.9 kg/m
2
 
are considered overweight, while those who have a BMI of 30 kg/m
2
 or higher are considered 
obese (2). Until recently, there was no consensus about the terminology for different levels of 
weight or BMI variation in literature for children. The new guidelines from the American 
Academy of Pediatric ended the discussion by forming a consensus of the terminologies 
(http://www.aap.org/). Considering the nature of continuing growth and different growth patterns 
between boys and girls between ages of 2–20 years, their BMI values must be adjusted for their 
age and gender. One way to do this adjustment is to plot on the CDC growth charts to determine 
the corresponding BMI-for-age percentile. Children with a BMI at or above 85
th
 percentile but 
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lower than the 95
th
 percentile are defined as overweight; and obesity is defined as a BMI at or 
above the 95
th
 percentile of the same age and sex (3).  
The standard CDC growth curves (CDC NCHS 2000) are based on nationally 
representative data from surveys conducted between 1963 and 1994 in five nations (NHANES I, 
II, III), which consists of a combination of formula- and breast-fed children (4). The standard 
WHO 2006 growth curves are based on data collected from a 6-yr Multi-Country Growth 
Reference Study in six different countries, including Brazil, Ghana, India, Norway, Oman and 
Davis, CA in the USA (5). The WHO 2006 growth curves are a growth curves appropriate for 
breastfed babies as this standard had been established with exclusively breastfed babies.  
 
Prevalence and Trends of Childhood Obesity 
Childhood obesity has become a big public health concern for the United States. The 
report from the National Center for Health Statistics (CDC) showed that the prevalence of 
obesity in children 2-5 years old has doubled from the period of 1994-1998 to 2007-2008 (from 
5% to 10.4% ) (6). A report from the National Health and Nutrition Examination Survey 
(NHANES), also suggested that more than 10% of the children between 2-5 years old were obese 
(7).   
 
Health Implications of Childhood Obesity 
There are many physical, psychological and social problems that can be related to obesity 
in children and adolescents (8). Obese children are at greater risk for bone and joint problems, 
diabetes, fatty liver, sleep apnea, higher levels of blood pressure and serum lipids (9). Also, 
obese children tend to grow more quickly than their peers, which may cause inappropriate 
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expectations of maturity level for their behavior. As a result of childhood obesity, negative self-
body image, exclusion from peers and low self-esteem can further lead to eating disorders, 
especially in girls (10).  
Obesity during childhood and adolescence also predisposes them to adulthood obesity 
(11,12) and its related health problems, such as T2DM and complications, dislipidemia, 
cardiovascular diseases, asthma, sleep apnea, acantosis nigricans, non-alcoholic hepatic steatosis 
(NASH), gallbladder, orthopedic problems, and cancer (13,14). Studies showed that 
approximately 80% of children who were obese during childhood and adolescence were obese 
adults at age 25 years (15,16). 
 
Obesogenic Environment and Behaviors for Childhood Obesity 
Because of the fast pace of modern life, fast food, sugar-sweetened beverages, prepared 
and processed food are more and more easily accessible and inexpensive, which all contribute to 
the development of poor eating habits in children (17).  
Increased screen time reduces physical activity and increases sedentary time, frequently 
accompanied by unhealthy eating habits (18). Recent studies showed that screen time (ie, 
television and computer time) is closely related to sedentary behavior and the onset of childhood 
obesity (19). Longer screen time is also associated with poor eating behavior in children because 
of the frequent food advertisements between children‘s programs on TV about low-nutrient high-
calorie-dense snacks (20). Studies showed that school-aged children with low cardiorespiratory 
or aerobic fitness have a higher risk of being overweight and are predisposed to obesity (21,22).  
Breastfeeding is also a vital factor that can influence a child‘s body weight. A meta-
analysis has shown that breastfed infants are less likely to be overweight or obese (23). In this 
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study, they also indicated that longer breastfeeding exerted stronger protective effects on 
children from becoming overweight or obese. Although the cutoff points of longer breastfeeding 
length in different studies were not consistent, the trend of stronger protective effects were 
showed clearly. Harder et al demonstrated in their study that a 4% decreased risk of overweight 
was observed with each month of breastfeeding, with 6-9 month exclusively exerting the biggest 
protective effect against later obesity (24).  
Low socioeconomic status is another risk factor for overweight. Compared to other 
environmental factors, socioeconomic status is more complex involving a combination of 
factors, including breastfeeding, maternal care, and smoking (25,26). Another study found that 
by the age of 18 years old, children from the lowest economic status had an average of 1.21 
kg/m
2
 higher BMI compared to children from the highest economic status (27). 
Many intervention programs that aim to address the current obesogenic lifestyle are 
ineffective for the most part (28,29). The concept of the "thrifty phenotype" was first introduced 
by Neel in 1960‘s (30). Basically, our genetic make-up helps us to survive by storing energy 
more efficiently as fat during famine, but this can be a huge disadvantage during the current 
food-abundant era. This ability to ―efficiently‖ store energy contributes to increase the 
prevalence of obesity in our current environment. Considering obesity as a complex trait 
resulting from both environmental and genetic factors, and interactions between the two, insights 
into genetic susceptibility manifested in the current obesogenic environment are needed.  
 
Genetic Studies  
In order to study the associations between genes and diseases, two different types of 
studies have been widely used – hypothesis-driven and non-hypothesis-driven studies. 
8 
 
Hypothesis-driven studies usually started with the hypothesis that particular gene or a set of 
genes are associated with a particular disease or phenotype, while non-hypothesis-driven studies 
usually scan the whole genome or a big range of genome to search for gene or genes related to 
the disease, such as genome-wide association study (GWAS).  Genetic studies can also be 
divided into Twin and family studies and non-familial relatedness studies. Twin and family 
studies are very good sources for heritability study. Heritability of BMI from generation to 
generation has been estimated to be around 60% -- 80% in several twin and family studies (31-
33). Children who have been adopted since young do not have BMI correlated to the BMI of 
their adopting parents but strongly correlated to the BMI of their biological parents (34). GWAS 
do not rely on familial relationships, which may greatly increases the sample size that could be 
involved in the study (35). Although the heritability of BMI is very high, when we look at the 
effect of both genetics and environment, common genetic variants explain only a small 
proportion of variation in obesity traits. A study of 20,000 people in the UK showed that 12 
SNP‘s explained only 0.9 per cent of BMI variation in that population (36).  
 
Regulation of Satiety and Appetite Control 
Food intake is one of the critical components impacting the onset of obesity, and it is a 
complex trait resulting not only from the physiological, psychological, and social effects but also 
from the influence of genetic predisposition. Many studies have indicated associations between 
eating behaviors, food preference, selection of proportion size and individual genetic variations 
(37-39). Food intake is regulated both peripherally and centrally. In the brain, the hypothalamus 
is a critical region for the regulation of food intake (40-42), as shown in Figure 1. It contains 
different neuronal populations or nuclei, including the arcuate nucleus (ARC), dorsomedial 
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nucleus (DMN), lateral hypothalamus area (LHA), paraventricular nucleus (PVN), and 
ventromedial nucleus (VMN). Among them, ARC is considered as one of the most important 
nuclei in satiety and appetite control.  
 
Genetic Risk Factors for Satiety and Appetite Control in Childhood Obesity 
Genes Potentially Involved in the Leptin-Melanocortin Pathway 
Two antagonistic arcuate neuronal subpopulations of ARC cells are orexigenic factors: 
agouti-related protein (AgRP) /neuropeptide Y (NPY)-containing neurons, and the anorexigenic 
factors proopiomelanocortin (POMC) /cocaine and amphetamine-regulated transcript (CART) 
neurons. Leptin is a polypeptide hormone secreted by adipose tissue. Its circulating levels in the 
blood are in proportion to total body fat storage (43). Normally, after a meal, leptin binds to the 
leptin receptor in the hypothalamus, a single-transmembrane-domain receptor of the cytokine 
receptor family, to inhibit the orexigenic factors AgRP/NPY. Concurrently, leptin also binds to 
the leptin receptors on the anorexigenic nuclei, resulting in the activation of the anorexigenic 
effects and thus the signal of fullness and satiety. When a loss-of-function mutation occurs in any 
of the genes LEP, LEPR, and POMC encoding leptin, leptin receptor and proopiomelanocortin, 
poor appetite control and obesity onset were observed (37,44,45). Another gene, FTO (Fat mass 
and obesity associated), has been shown to have demethylase activity (46). Although the exact 
mechanism of how FTO works is still not clear, many studies have associated its function with 
satiety suppression (47-49), and it is also hypothesized to have an effect of downregulating leptin 
(50).  
10 
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Prohormone convertase subtilisin/kexin type 1(PCSK1) gene encodes the prohormone 
convertase 1/3 (PC 1/3) that converts prohormones such as proinsulin, proopiomelanocortin  
(POMC) into their biologically active forms in neuronal and endocrine tissue (51). Mutations in 
PCSK1 have been associated with monogenic obesity and obesity-related phenotypes in several 
studies (52-59). Activation of POMC in the central nervous system by leptin leads to the 
production of tissue-specific proteolytic melanocortin peptides (α-MSH and β-endorphins) in the 
presence of the PCSK1 enzyme. Those peptides act on melanocortin receptors as agonists (60). 
Melanocortin plays a central role in the regulation of food intake and energy homeostasis. 
Melanocortin-4 receptor (MC4R) expressing neuron is one of the five related G protein-coupled 
neuron receptors. Studies have shown a strongly consistent association between MC4R 
mutations and loss of satiety signal, and the onset of obesity (61-63). The synthetic melanocortin 
peptides stimulate the expression of the secondary neuron effectors, brain-derived neurotrophic 
factors (BDNF) in the higher cortical area in the brain (64). Genome-wide association studies 
have indicated significant association between the BDNF gene and BMI (65,66).  
Another protein, tubby protein (TUB), is a member of the novel multigene family and is 
highly expressed in the ARC, PVN and VMH of the hypothalamus (67). Loss-of-function 
mutations in the gene TUB, encoding the tubby protein, result in tubby obesity syndrome in the 
mouse model (68). A couple of studies have suggested that TUB may work as a transcription 
factor and may influence downstream insulin signaling and G-protein-coupled receptors, 
including MC4R (69,70). 
Mutations in genes encoding key effectors and receptors of the hypothalamic leptin-
melanocortin pathway, BDNF, LEPR, FTO, PCSK1, LEP, TUB, POMC, and MC4R have been 
shown to be significantly associated with children weight regulation through satiety and appetite 
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related behavioral traits. However, very little effort to map out how all these genetic variations 
work together has been done in this preschool age children group. Knowing that a child with 
specific gene-related predisposition to obesity may not experience a sense of satiety may help us 
to better understand their eating behaviors and to develop personalized prevention and 
intervention strategies for childhood obesity.  
 
LEP and LEPR  
Many peripheral hormones are involved in the control of energy balance, such as leptin, 
insulin, ghrelin and thyroid hormones. Among them, leptin, a polypeptide generated in 
adipocytes, sends signal of body fat storage to the hypothalamus. Leptin has been demonstrated 
to be closely associated with satiety and appetite control (71). High circulating level of leptin 
decreases body fat storage by suppressing food intake and increasing energy expenditure, 
through leptin receptor, a single-transmembrane-domain receptor in the class 1 cytokine receptor 
family (72).  
In mice, haploinsufficiency of LEP and LERP, the genes encoding leptin and leptin 
receptors, cause increased adiposity (73).  In humans, those individuals with a loss-of-function 
mutation on LEP or LEPR gene showed symptoms of binge eating (74), disphagia, early-onset 
obesity, and increased deposition of fat mass (37,44). 
The LEPR SNP rs1137101 is one of the most common variations among different 
populations. The G allele at this locus causes an amino acid change from glutamine to an 
arginine (75). This variation has been linked to food preferences and phenotypes of obesity in 
adults (76). Also, it has been inconsistently linked with increased risk of obesity in many studies 
(75-83). The combination of the minor alleles from LEPR rs1137101 and LEP c.-2548G>A, the 
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G/G genotype, has also been linked to a 58% increase in risk of being obese (84). Results from a 
study with Tunisian obese patients showed that the rs1137101 polymorphism has a significant 
effect on the BMI and plasma leptin levels of obese subjects (52). However, Farooqi‘s study 
found no difference in serum circulating leptin level between subjects carrying LEPR gene 
mutations and those not carrying mutations (38). Therefore, leptin levels may not be a good 
marker for the detection of LEPR gene mutations or LEPR deficiency.  
The preschool period (age 2 to 5 years old) is a critical period for the development of 
overweight and onset of obesity (85). Some associations studies between LEPR variations and 
onset of obesity in school-aged children and adolescence have been reported, but the results are 
not consistent. The Lys656Asn polymorphism of the LEPR gene was reported to be associated 
with cholesterol level in Thai children and adolescents (5-19 years old) (76). Okada‘s study 
suggested that LEPR gene polymorphisms may partly contribute to the serum lipid profile in 
obese children (86). However, no associations were found between the LEPR rs1137101 
polymorphism and BMI in Pyrzak‘s study (87). Furthermore, no significant associations have 
been found between the LEPR rs1137101 variation and serum leptin levels, which may be due to 
the lack of a direct inversely proportional relationship between them, as indicated in Farooqi‘s 
study (38).  
 
POMC 
Proopiomelanocortin (POMC) /cocaine is one of the two antagonistic ARC neural 
populations, which is inhibited during food deprivation due to low leptin and thyroid hormone 
levels and high corticosterone and ghrelin leveles. POMC is a polyhormone peptide, which is 
mainly expressed in the brain and yields a variety of biologically active peptides by a tissue-
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specific posttranslational conversion, including alpha-MSH and beta-MSH. In this way, POMC 
gene encodes both alpha-MSH and beta-MSH, and several other polypeptides. The product of 
the POMC gene acts on melanocortin receptors as an agonist (60), which is potentially involved 
in the regulation of serum leptin concentrations and associated with obesity (88).  
POMC knockout mice display hyperphagia and the onset of obesity (89). However, there 
are not many studies in humans, especially in children, partially because mutations in the POMC 
gene are relatively rare. Variations of Tyr221Cys in beta-MSH cause its products unable to 
appropriately bind to the melanocortin receptors and thus cannot be activated to send correct 
signals to the downstream neurons. This polymorphism has been associated with hyperphagia 
and early-onset childhood obesity (45). One study in Caucasian children did not find any 
significant association between POMC variants and increased risk of obesity (90).  
 
TUB 
The tubby protein is highly expressed in the ARC, PVN and VMH of the hypothalamus, 
which is a critical area in regulation of satiety and appetite control (91-93). The gene encoding 
the tubby protein, the TUB gene, is evolutionarily conserved (94). A couple of studies have 
suggested that TUB may work as a transcription factor and may influence downstream insulin 
signaling and G-protein-coupled receptors, including melanin concentrating hormone (MCH) 
receptors, melanocortin 4 receptors (MC4R), and dopamine D1 receptors that coupled the Gq 
subclass of Ga proteins (69,70,95). In mice, loss-of-function mutations in the TUB gene caused 
maturity-onset obesity, insulin resistance and sensorineural hearing deficits (68). Loss-of-
function in the TUB gene also resulted in a 20% significant reduction in expression of POMC 
mRNA in ARC, 30 time upregulation of NPY mRNA in DMH and VMH (96), and expression 
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alteration of AGRP mRNA in ARC (97). Variants in the TUB gene were found to be associated 
with BMI, body composition and macronutrient intake in a Dutch population (98,99). One of the 
variants, SNP rs2272382 is located in the noncoding region. The major allele (G) for the 
rs2272382 SNP was associated with a decrease of BMI in 1.3 kg/m
2
 per allele in the Breda 
cohort (98). The study also indicated that the minor allele (A) and the homozygous genotype 
(AA) were more prevalent among people who were overweight or obese. This suggested that the 
G allele may exert a protective effect in human body weight regulation and the A allele may put 
people at a greater risk of increased weight. However, to date, the results of genetic studies for 
the TUB gene are not consistent. Another five SNPs around TUB gene were investigated in 716 
Pima Indians, but no significant associations were found (100).  
NPY/AGRP and POMC-containing neurons have been proven to be important orexigenic 
and anorexigenic factors in the regulation of satiety and appetite. The significant link in the 
expression levels of the NPY, AGRP and POMC mRNA suggested the potential function of the 
TUB gene in the of satiety and appetite control system. Further investigations into the exact 
mechanism of how the TUB gene and its variations influence human weight regulation are still 
needed in order to discover the underlying mystery. 
 
PCSK1 
Prohormone convertase subtilisin/kexin type 1 (PCSK1) encodes the prohormone 
convertase 1/3 (P/C 1/3) that converts proinsulin, pro-opiomelanocortin, and proglucagon into 
mature hormones (101). Mutations in the PCSK1 gene in mice resulted in proinsulin and pro-
opiomelanocortin processing defects and the onset of obesity (102). In humans, PCSK1 
deficiency and PCSK 1 disruption cause hyperphagia, severe childhood obesity, compromised 
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glucose tolerance, and GI absorptive problems (54,55,102). One of the SNPs in the PCSK1 gene, 
rs6235 (Ser690Thr), is non-synonymous and highly correlated with the rs6234 SNP at the C 
terminal of the protein. The rs6235 SNP was shown to be strongly associated with obesity 
measurements in several independent European cohorts, with a 1.22-fold increase in risk of 
being obese for each risk allele carried (52). However, no significant linkage was detected in 
other studies which were also based on European population (65,66,103,104). Interaction effect 
between the SNP and age on the BMI phenotype has been suggested (104).  
 
FTO 
The FTO (Fat mass and obesity associated) gene is the second well-replicated genetic 
variation that has been found to correlate with BMI. Current studies have consistently and clearly 
implicated that the FTO gene has a significant impact on food intake and obesity. Although there 
is still much to be known about the exact mechanism of the gene, FTO has been shown to have 
demethylase activity (46). Fasting status leads to a dramatic decrease in FTO expression in the 
hypothalamus, which suggests a potential appetite suppressing effects of this gene (46,105).  
Many studies in children showed that genetic variants in the FTO gene are associated 
with BMI and predispose children to obesity through increasing energy intake (49,106,107). 
Recent studies have confirmed that a common FTO variant, rs9939609, has significant 
association with weight, BMI, BMI standard deviation score (BMI Z scores), and waist 
circumference under an additive model in European, African American, and Chinese children 
and adolescents, but the results did not show consistency in the associations with body fat 
percentage (108,109). The T allele in the FTO gene on this locus may contribute to improve 
satiety responsive and thus protect children from overeating, loss of control eating (48,110,111). 
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However, differences in effects between age groups and gender have been detected in some 
studies for the rs9939609 SNP. In Hardy‘s study, the FTO SNP rs9939609 showed the most 
significant association with BMI Z scores during childhood and adolescence (P < 0.001) with a 
peak association at the age of 20 and then weakening after that (P = 0.001) (112). Also a study 
by Hakanen indicated that the effect of the FTO genotype on BMI becomes evident only after the 
age of 7 (113). Another report by Jacobsson et al., included 962 Swedish children and 
adolescents, found that the A allele variant of the FTO SNP rs9939609 predisposed girls to be 
obese but not boys, with an increase of both BMI and BMI Z scores (114).  
Researchers have found a similar trend for other SNPs located in FTO gene, including 
rs3751812, rs1421085, rs1558902, rs9935401. Strong associations between these SNPs and the 
early onset childhood obesity have been detected (115,116). Improved understanding of the 
effects of the FTO individual variants, especially in children, could offer new insights into the 
etiology of excess adiposity.  
 
MC4R 
Melanocortin 4 receptor (MC4R) is a downstream receptor in leptin signaling pathway in 
central melanocortinergic system, which plays a vital role in metabolic regulation and energy 
intake. Leptin circulates in proportion to body adiposity and regulates appetite and energy 
expenditure. The MC4R gene was one of the first and most widely studied loci from which 
genetic variations were associated with human obesity (117). Variations in the MC4R gene are 
also the most common cause for monogenic forms of obesity (118, 119,120).  
The Viva
 
la Familia Study consisting of 631 Hispanic parents and 1030 children showed 
a suggestive association between 25 SNPs in the coding or flanking regions of the MC4R gene 
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and body size, adiposity, glucose, insulin,
 
leptin, ghrelin, energy expenditure, physical activity, 
and
 
food intake (61).  
Recently, modest but generally consistent replication attempts have yielded consistent 
outcomes regarding an association between obesity and the rs17782313 SNP from genome wide 
association (GWA) studies. Loos‘s study in 2008 included both adults and children samples of 
European descent, and established that the common variant (rs17782313) near the MC4R gene 
was influential in fat mass, weight and thus obesity risk (62). However, one study conducted in 
the city of Santiago (Chile) with 221 obese children (age 9.5 ± 2.4 years old) and 268 parents 
detected no significant association between the rs17782313 SNP and children‘s height-for-age z-
score (HAZ) as well as children‘s waist-to-height ratio after adjusting for age, gender and BMI z-
score. However, the study indicated that the rs17782313 variation may be associated with 
children‘s satiety and enjoyment of food (121). One longitudinal study genotyped variant 
rs17782313 near MC4R in 1240 men and
 
1239 women born in 1946 and participated in the MRC 
National
 
Survey of Health and Development in the United Kingdom (112). It showed that the 
association between the rs17782313 variation and body weight peaked at the age of 20, and 
diminished with increasing age. However, Grant et al.‘s studies showed inconsistent associations 
between BMI and SNPs rs571312, rs10871777, and rs476828 (perfect surrogates for 
rs17782313) near the MC4R gene in European American and African American children. 
Variants at the 3‘ of MC4R locus showed significant risk for Caucasian children but not in the 
African American samples (63).  
Variants of the MC4R gene found in both African Americans and Caucasians may 
represent more universally important associations with obesity. However, studies of Americans 
of Asian ancestry are missing. Additional studies in children, especially preschool aged children 
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are still needed, considering the importance of this age period in the development of obesity in 
the life.  
 
BDNF 
BDNF is a member of the neurotrophin signaling protein family with 119 amino acids 
(122). BDNF and its receptor, tropomyosin-related kinase B (TrkB), are expressed at high levels 
in VMH nuclei regions. Its expression is regulated by nutritional status and also by MC4R 
signaling (64).  
The ventromedial hypothalamus and the BDNF gene have been associated with satiety, 
appetite control and regulation of energy metabolism in both mice and human beings. Although 
the exact neural mechanisms on how the VMH regulates energy balance remain unknown, 
lesions of the bilateral VMH have been observed to cause hyperphagia and obesity (123,124). It 
is suggested by Xu that BDNF is an important effector through which MC4R signaling controls 
energy balance (64). BDNF is thought to be involved in several trophobiological effects, 
including neurotrophic, immunotrophic and metabotrophic effects, and plays an important role in 
neuro-metabotrophic deficit in the pathogenesis of obesity (125). Although the exact mechanism 
by which BDNF influences energy balance and the association of its receptor signaling to the 
previously known energy- regulation pathways is still not clear, many studies in mice suggest 
that BDNF affects locomotor behavior and regulates food intake through a central maintenance 
mechanism. One study showed that appetite inhibition requires BDNF synthesis in the VMH 
(126). BDNF gene expression is reduced in heterozygous mice, and all heterozygous mice 
exhibited abnormalities in eating behavior or locomotor activity. Phenotypes of obesity onset, 
hyperactivity, aggressiveness, hyperleptinemia, hyperinsulinemia, hyperglycemia and increased 
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linear growth have been associated BDNF heterozygous mice and BDNF-deleted mice (127-
129). Conditional BDNF mutant mice, where BDNF is eliminated in a tissue- and temporal-
specific manner after birth, develop mature-onset obesity and aspects of metabolic syndrome 
(129). Analysis of these mice revealed that BDNF functions importantly in the control of both 
anxiety-related and eating behaviors. Infusion with BDNF can transiently reverse the eating 
behavior and obesity. Both central and peripheral administration of BDNF decrease food intake, 
increase energy expenditure and ameliorate hyperinsulinaemia, hyperleptinemia and 
hyperglycemia in diabetic C57BL/KsJ-db/db mice or mice with BDNF haploinsufficiency (130-
133). Brain infusion of BDNF to mice with MC4R insufficiency showed suppression of their 
hyperphagia and excessive weight gain (64). Chronic treatment with BDNF regulates energy 
expenditure in obese diabetic mice, partly through activating the sympathetic nervous system and 
inducing UCP1 gene expression in BAT (133). Also, mutants with lower expression of TrkB 
levels in mice resulted in hyperphagia and abnormal weight gain in mice fed a higher fat diet 
(64).  
In humans, studies of obese patients with Wilm‘s tumor, aniridia, genitourinary 
anomalies, and mental retardation contiguous gene syndrome suggested a significant role of 
BDNF in the onset and development of obesity (134). BDNF haploinsufficiency in patients with 
WAGR syndrome is associated with lower levels of serum BDNF and also hyperphagia and 
early onset childhood obesity (135). One study showed that serum BDNF is lower in obese 
children (136). Another study has associated mutations in TrkB with severe childhood obesity 
onset and development retardation (137).  
Several SNPs located within or downstream of the BDNF gene have been indicated with 
strong association with BMI, including rs6265 (Val66Met, non-synonymous), rs4074134, 
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rs4923461, rs10501087, rs925946, rs10835211, and rs7481311 (65,138). Among them, rs6265 
has been linked mainly with neurological and psychiatric disorders, and eating behavior and BMI 
(139,140). Three of the other SNPs, rs4074134, rs4923461, rs10501087 are strongly correlated 
with rs6265 all with r
2
 of 0.85 (in linkage equilibrium). The other three SNPs, rs925946 
(r
2
=0.12), rs10835211 (r
2
=0.09), and rs7481311 (r
2
=0.07) were weakly correlated to rs6265 and 
may be another block of association signal ―tag SNPs‖ (65). The effect size of BDNF variant 
rs925946 was twice as large in children (age 9.7 ± 0.4 years) and adolescents (15.5 ± 0.5 years) 
as it was in adults (141). Further studies in the preschool aged children are still needed to further 
confirm this finding.  
Basic information of the SNPs covered in the literature review part is listed in table 1.  
 
SNP, genotyping and genotyping methods 
Single Nucleotide Polymorphims (SNPs) have been well-known as good genetic markers 
to study the association between genetic variations and complex traits (142). SNPs are widely 
and densely distributed in the human genome, about one SNP every 500–1,000 base pairs. 
Different platforms of SNP genotyping have been developed with different methods of SNP 
selection, reaction mechanisms, signal detection, cost and flexibility. A wide variety of advanced 
genotyping techniques, including Taqman genotyping and TDI-Fluorescence Polarization (FP) 
genotyping provide high throughput, high accuracy and low cost methods to study the complex 
traits. FP is an inexpensive, high-throughput method for genotyping. It is based on the 
mechanism that when we excite a fluorescent molecule by plane-polarized light, a proportional 
light can be detected and used to separate the different molecules by different molecular weight 
(143).  
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Table 1. Basic Information of Genes and SNPs  
Gene SNP Location Sequence Minor Allele Allele Freq 
BDNF rs925946 Chr11 GTGA[G/T]TAAA T 0.355 
  rs6235 Chr11 ACAC[A/G]TGAT A 0.184 
FTO rs8057044 Chr16 ACCT[A/G]GAGG G 0.461 
  rs9939609 Chr16 ATTT[A/T]GTGA A 0.436 
LEP rs7799039 Chr7 TTGC[A/G]Ctga A 0.317 
LEPR rs1137101 Chr1 TTCC[A/G]GTCA A 0.482 
MC4R rs17782313 Chr18 ATCC[C/T]GATG C 0.259 
PCSK1 rs6235 Chr5 CCAA[C/G]TGCA C 0.278 
POMC rs934778 Chr2 TCAC[C/T]GGCA C 0.384 
TUB rs2272382 Chr11 CCAC[A/G]GCCC A 0.378 
 
Table 1 shows the SNPs and genes in this leptin-melanocortin pathway and their prevalence in 
the Caucasian population.  
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Taqman method uses hydrolysis probes in real-time PCR assays (144). Compared to FP, 
it has fewer choices in probes because of the limited premade probe database; however, it is 
quicker than the FP method mainly by saving the time to test the genotyping conditions. FP use 
less expensive primer sets and need a very small amount of fluorescence dyes. The database for 
previously used primer sets is limited as well, but users can design effective and specific primer 
sets in order to get the right products. On one hand, this provides us more flexibility on the 
selecting of the SNPs. On the other hand, it requires more primer design knowledge and higher 
molecular biology skills.  
Recently, next-generation sequencing technologies are revolutionizing the way research 
is conducted in molecular biology and genetics. Illumina sequencing and SOLiD are two of the 
new technologies are being used widely, although both of them have its drawbacks. The next 
next-generation of sequencing technology is approaching too.  
 
Effect of Breastfeeding on the Association 
Breast milk is the best source of nourishment for infants. Breastfed infants are less likely 
to be overweight later in life than infants fed formula. A meta-analysis found that 7 out of 9 
studies showed a significantly lower risk of overweight among children who were breastfed 
(145). Longer breastfeeding duration has also been proven to exert stronger protective effect on 
children from being overweight or obese.  
Adding breastfeeding as a covariate in an association studies with the FTO gene 
suggested a protective effect on children from being overweight or obese (146). It is possible that 
breastfeeding exerts a modifying effect on the association between genetic profile and the 
overweight and obese phenotypes.  
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Conclusion 
Some genes related to the melanocortin-leptin pathway showed overlap on its influence 
in both rare monogenic obesity and common polygenic obesity. Common SNPs that have been 
widely seen in the monogenic obesity, such as PCSK1, and MC4R, also showed significant 
association with the obesity related phenotypes in the general population at different age (53,54, 
62,147,148).  
Differences observed in the results of the genetic studies may be due to the different age 
of population examined. Genetic predisposition may exert stronger and a more exclusive 
influence in younger populations, which indicated the importance of studying the candidate risk 
genes for obesity in children, especially school age children. Early awareness of risky behaviors 
and personalized intervention can effectively prevent children from carrying on their ―genetic 
risk‖ later into life and become obese.  
The preschool period has been identified as an important time for the development of 
eating behaviors and thus childhood obesity (149-151). Development of preschool age children 
is more malleable and thus the prevention and intervention at this age period can be more 
effective and easier (152,153). Further investigations into the function of the specific genes are 
still needed, for example, FTO and BDNF.  
We hypothesize that individual genetic variations related to satiety and appetite control in 
the BDNF, FTO, LEP, LEPR, MC4R, PCSK1, POMC, and TUB genes are associated with the 
risk of obesity in preschool-age children. The objectives of current study are tree-fold: 1) to 
investigate the association between obesity related phenotypes and genetic variations; 2) to 
investigate the association between genetic variations with satiety and appetite control, and 3) to 
investigate the association between the obesity phenotypes and satiety and appetite control. 
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CHAPTER 3 
Individual Genetic Variations Related to Satiety and Appetite Control Increase Risk of 
Obesity in Preschool Age Children from STRONG Kids Program 
ABSTRACT 
Objective: To investigate whether the previously reported genetic associations between the 
single-nucleotide polymorphisms (SNPs) and phenotype of obesity hold in Caucasian preschool 
children in the STRONG Kids Program cohort 1. 
Methods: Height and weight were measured in 128 Caucasian preschool children from the 
STRONG Kids Program (age 39.9 + 2.0 months, BMI 16.5 + 1.2 kg/m
2
).  Genomic DNA was 
extracted from saliva samples and used for genotyping. Eight SNPs rs925946, rs1137101, 
rs8057044, rs6235, rs934778, rs2272382, rs7799039 and rs17782313 within or near the BDNF, 
LEPR, FTO, PCSK1, POMC, TUB, LEP, MC4R genes were genotyped by either FP-TDI assay 
or TaqMan SNP genotyping assay. Statistical analyses were performed with SAS 9.2 and p-link 
software to test the association between genotype and anthropometric data, and to calculate the 
genetic scores.  
Results: In this cohort, 25 children (19.5%) were overweight and 8 children (6.3%) were obese. 
There were significant associations between the height-for-age z-score and the rs2272382 SNP 
on TUB (P=0.0021) after adjusting for breastfeeding duration. The SNP rs17782313 in the 
MC4R gene also showed significant association with height-for-age z-score (P=0.038) before, 
but not after, adjusting for breastfeeding duration. As the number of risk allele increases, the risk 
of being obese or showing the first signs of being obese also increases.  
39 
 
Conclusion: Our observation suggested that genetic variants on TUB, MC4R, BDNF and LEP 
are related to the risk of obesity in our cohort; as the number of risk alleles increases, the risk of 
early-onset obesity increases.  
 
INTRODUCTION 
Obesity is a severe public health problem in the United States. Until recently, the obesity 
prevalence has been increasing steadily in children. According to the CDC, in 2007-2008, 16.9% 
of children in the United States between 2 and 20 years were obese (at or above the 95
th 
 
percentile of BMI for age); and 31.7% Children were overweight (at or above the 85
th
 percentile 
of BMI for age). Approximately 80% of individuals who were obese during childhood and 
adolescence remain obese as adults (1). 
The STRONG (Synergistic Theory and Research on Obesity and Nutrition Group) Kids 
is a 3-yr longitudinal, cross-disciplinary study designed to identify risk factors for excessive 
weight gain and obesity development in preschool-age children. The STRONG Kids study was 
developed under an ecological framework with several spheres of influence that we called the six 
Cs‘ model: Cell, Child, Clan, Community, Country, and Culture (2). We study effects of these 
environmental factors, their interactions on the childhood obesity-onset and the sphere of 
biological influence (―the Cell‖), which encompasses the genetic and metabolic individuality that 
affects the risk of diseases associated with childhood obesity (3).  
Increased food intake, is one of the critical factors leading to the onset of obesity. 
Regulation of food intake is a complex trait resulting from the interaction of physiological, 
psychological, socio-environmental elements, and an individual‘s genetic profile. In fact, several 
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studies have indicated that there is an association between eating behaviors, food preferences and 
selection of proportion size with individual genetic variations (4-6). 
The hypothalamus satiety and appetite control system is complex and involves many 
pathways. The leptin-melanocortin signaling pathway is well-recognized for its critical function 
in appetite control. Individual variations in genes involved or potentially related to this pathway 
(i.e. BDNF, FTO, LEP, LEPR, MC4R, PCSK1, POMC, TUB) have been associated with 
symptoms of poor appetite control and obesity-related phenotypes (4,7,8). In fact, genetic 
variations in MC4R and BDNF are commonly identified in children with severe early-onset 
obesity (9,10). Therefore, knowing that a child with specific gene-related obesity predisposition 
may not experience a sense of satiety could help us to better understand their eating behaviors 
and to develop personalized prevention and intervention strategies.  
The preschool age (before 5 years old) is a critical period for children to establish food 
intake patterns (11). The purpose of this study was to investigate previously reported genetic 
associations between the single-nucleotide polymorphisms and the obesity-related phenotypes in 
2 to 5 year-old children participating in the STRONG Kids Research Program. The selection of 
genes for our study was based on a hypothesis-driven candidate gene approach. We selected only 
genes that had a well-defined role in regulating the hypothalamic satiety signaling pathway and 
individual variants that have been associated with obesity-related traits.  
 
SUBJECTS AND METHODS 
Sample Collection and DNA Extraction  
Our sample population consisted of 128 Caucasian children from the STRONG Kids 
Program (age 39.9 + 2.0 months, BMI 16.5 + 1.2 kg/m
2
). Anthropometric data (including height 
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and weight) were collected by trained personnel at 30 day care centers in the central Illinois area 
by using a stadiometer (Peslter, USA) and an electronic remote display scale (Health-o-Meter, 
Jarden Consumer Solutions, USA). The precision level was 0.1 cm for height measurement and 
0.1 kg for weight measurement. Saliva samples were collected by using the Saliva Collection Kit 
for Young Children (DNA Genotek Inc., Canada) in order to extract the genomic DNA for 
genotyping.  
Anthropometric Measurements 
Z-scores, including weight-for-age (WAZ), height-for-age (HAZ), weight-for-height 
(WHZ) and BMI-for-age (BMIZ) z-scores, express standard deviation from the mean to indicate 
a child‘s weight and height status across age and gender according to the 2000 Centers for 
Disease Control (CDC) growth charts. They were calculated by using the standard SAS Program 
from CDC (CDC, 2010). 
DNA Extraction 
Genomic DNA was extracted from saliva sample according to the protocol adopted from 
manual for the purification of DNA from 4.0 mL of Oragene DNA/saliva. The average DNA 
yield was 4.17 μg with an average 260/280 OD ratio of 1.80 + 0.21 measured by NanoDrop 
(Thermo scientific, USA).  
Genotyping  
Fluorescence Polarization 
Template-directed dye-terminator incorporation with the fluorescence polarization 
detection was used for genotyping of SNPs rs925946, rs1137101, rs8057044, rs6235, rs2272382, 
rs7799039 in or near the genes of BDNF, LEPR, FTO, PCSK1, TUB, LEP, respectively. PCR 
reactions were performed with 5ng dry genomic DNA, followed by the single base pair 
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extension procedure according to the protocol developed by Kwok (12). Fluorescence signal was 
read by the VICTOR Multi-label Plate Reader (Perkin Elmer Life Sciences, Massachusetts, 
USA). Genotypes were called independently by two persons without discordance. To check the 
accuracy of genotyping and genotype assigning for each SNP, we repeated at least 10% of the 
samples randomly including both positive and negative controls. The concordance for replicates 
was 100%.  
Taqman 
The MC4R marker, rs17782313, was genotyped by predesigned allelic discrimination 
Taqman assays (Applied Biosystems, Foster City, CA) and the GeneAmp 7900 Real Time PCR 
System (Applied Biosystems). PCR was performed in a 384-well format in a 5µl reaction 
volume (2.5µl Taqman Universal Master Mix, 0.125 µl 40x SNP FAM/VIC dye labeled allelic 
genotyping probes and 2.25µl molecular grade water) with 5ng of dry genomic DNA and 
subjected to 95˚C for 15 minutes, and 40 cycles of 92˚C for 15 seconds and 60˚C for 1 minute on 
and the GeneAmp 7900 Real Time PCR System (Applied Biosystems, Foster City, CA). 
Genotypes were assigned using Sequence Detection Software 2.4 (Applied Biosystems, Foster 
City, CA) with a success rate of 95.5%.  
Statistical Analysis  
Selected SNPs were tested for additive genotype effect on BMI percentile, WAZ, HAZ, 
and BMIZ values in linear models using SAS 9.2 (SAS Institute Inc., Cary, NC, USA). General 
linear models were adjusted for breastfeeding length as a categorical covariate. The three 
categories of the breastfeeding length were never been breastfed, breastfed but less than 6 
months, and breastfed for 6 months or more. Allele frequencies were estimated by the gene 
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counting method, and the chi-square test was used to identify significant departures from Hardy-
Weinberg equilibrium. 
PLINK (http://pngu.mgh.harvard.edu/purcell/plink/), a genotype/phenotype association 
analyses software (13), was used to investigate the association of WAZ, HAZ, BMIZ phenotypes 
with the number of risk alleles for the genotyped SNPs. 
 
Results 
We genotyped 128 Caucasian subjects. The mean and 95% confidence intervals for age, 
weight, height, BMI and z-scores are shown in Table 2. No significant differences in age, height, 
BMI, or z-scores were detected between boys and girls, or in groups with different breastfeeding 
length. Ninety seven (75.8%) children had ever been breastfed in this cohort, which is very close 
to the reported ―National Ever Breastfed Rate‖ of 74% in 2010 (14).  
The minor allele frequencies of this Caucasian cohort are shown in Table 3. Minor allele 
frequencies of all the alleles are quite consistent with the reported for Caucasian population from 
the Hapmap 37.1 (http://www.ncbi.nlm.nih.gov/pubmed/). Although we detected different minor 
alleles in the rs1137101 and rs8057044 in our population, the discrepancy with the reported 
allele frequencies is not remarkable for either SNP since the minor allele frequencies are close to 
0.5. We did not detect any significant deviation from Hardy-Weinberg equilibrium for any of the 
SNPs investigated, in spite of the small sample size of this cohort (Table 3). 
The associations of individual SNPs with HAZ, WAZ, and BMIZ are summarized in 
Table 3. The SNP rs17782313 in the MC4R gene was significantly associated with HAZ 
(P=0.0376). This association remains significant after adjustment of breastfeeding length 
(P=0.0322). When testing other SNP-HAZ associations, we did not found any interactions 
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between this SNP and breastfeeding in a model that included breastfeeding as a covariate. 
However, we found borderline significant association for the rs7799039 SNP with HAZ 
(P=0.0696). This remained after adjustment of breastfeeding (P=0.0524). However, when 
breastfeeding was incorporated as covariate, the association between the SNP and the HAZ was 
significant (P=0.0141). The minor allele (A) at the SNP of rs7799039 on the LEP gene was 
significantly associated with an increase of HAZ at 0.26 per allele (P=0.027). 
We did not find any association related to the SNP rs2272382 in the TUB gene either by 
itself or after adjustment of breastfeeding length. However, when we tested the interaction 
between the SNP and breastfeeding length, significant interaction between the SNP and 
breastfeeding length was found (P=0.0021).  
The genetic predisposition score for WAZ, HAZ, and BMIZ were all normally distributed 
(Figure 2). We also observed that the number of risk allele increases, the risk of having higher 
BMI percentile, HAZ, and WAZ increases (Figure 2). 
 
Discussion and future directions  
We were able to replicate the allele frequencies reported before for other Caucasian 
populations (15). Also, our results showed that rs2272382, rs17782313, rs7799039 and rs925946 
within or near the TUB, MC4R, LEP and BDNF genes were associated with measures of obesity. 
Except for the SNP in the BDNF gene, which is directly linked with BMI percentile, all the other 
three SNPs indicated stronger influence on the height-for-age in this cohort of children. This 
observation concurs with the previous report that taller children are more likely to become 
overweight or obese compared to their normal height counterparts (16).  
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In our cohort, the selected marker in the TUB gene (rs2272382) and breastfeeding 
interaction was associated with HAZ. Individual genetic variations in the TUB gene have been 
associated with BMI, macronutrient intake pattern, and late-onset obesity in middle age 
populations (10, 11-13). Our study, for the first time, indicated the association of the rs2272382 
polymorphism on preschool-age children. This may suggest that at different stages of life, certain 
characteristics become more or less relevant, having impact on different phenotypes.  
Reports about the association between the common variant rs17782313 near MC4R gene 
in children are inconsistent (9,17-20). In our current cohort, we were able to detect the 
association between HAZ and this genetic marker. However, by including breastfeeding length 
as a covariate and interaction term, we could not observe the association with the phenotype. It is 
possible that breastfeeding is exerting a protective effect on the genetic association between 
polymorphism of this SNP and obesity related phenotypes, which is supported by Dedoussis‘s 
study (21).   
We were able to detect normally distributed genetic predisposition scores in our cohort 
despite for the small sample size. The allele frequencies observed were very similar to what have 
been reported elsewhere (22). Importantly, the eight SNPs we investigated in our cohort showed 
cumulative effects on WAZ, and BMI percentile. Children with 12 risk alleles on these markers 
have an average 1.2 units higher WAZ than children with only 3 risk alleles. However, the 
effects of all combined variants explain less than 0.1 percent of the variability in the WAZ 
phenotype.  
Several limitations of this study should be noticed. First, our study may be underpowered 
by the small sample size to detect some associations. That may also lead to false-positive results. 
46 
 
Further replications in bigger cohort are still needed. Second, a few samples (n=18, 14.1%) were 
not completely genotyped for all eight SNPs, which may influence the reported genetic scores.  
In the STRONG Kids Program, we obtained extensive phenotype and environmental 
impact data. In future analyses, we will be able to investigate the genetic and environmental 
effects and their interactions more comprehensively.  
In conclusion, common genetic variants for obesity related phenotypes have small but 
cumulative effects on obesity risk for preschool age children. Current literature has clearly stated 
the importance of genes involved in or related to the melanocortin-leptin pathway in the 
regulation of satiety and risk of obesity. However, one difficult question remains—to what extent 
and if so, how do these genes and alleles work to regulate molecular pathways? For some loci 
that have been identified as being associated with obesity or obesity-related phenotypes, the 
functional role of these genetic variations remains to be elucidated. Many of the current studies, 
particularly some genome wide-association studies, have highlighted the importance of multi-
locus effects on the genetic contribution to the onset of obesity. It is still premature to know 
whether individualized pharmacologic treatment will be fulfilled and makes big difference in the 
control of energy balance; however, it will be useful for parents to become aware of the risk of 
certain behaviors and help the children to practice proper eating habits before the gun of genetic 
predisposition is triggered in the current obesogenic environment.  
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Table 2. Descriptive Characteristics of the 
STRONG Kids Caucasian Cohort (N=128) 
Variable Mean 95% CI 
Age (mo.)
1
 39.9 38.6 41.1 
Weight (kg) 15.6 15.2 15.9 
Height (cm) 97.1 96.1 98.1 
BMI (kg/m2) 16.5 16.3 16.7 
BMIPCT
1,2
 65.3 61.1 69.5 
WAZ
1
 0.4 0.2 0.5 
HAZ
1
 0.1 -0.1 0.3 
WHZ
1
 0.5 0.3 0.6 
BMIZ
1
 0.5 0.4 0.6 
1
According to the 2000 CDC Growth Chart 
2
BMIPCT: BMI percentile 
Table 2. Descriptive Characteristics of the STRONG Kids Caucasian Cohort (N=128). Mean and 
95% confidence intervals are shown.  
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Table 3.  Basic SNPs Information and Association with z-scores             
SNP Gene 
Basic Information 
SKP Caucasian 
Cohort (n=128) 
Association (P-value) with 
HAZ 
Association (P-value) with 
WAZ 
Association (P-value) 
with BMIZ 
Location 
Reported 
MAF
1
 
Detected 
MAF 
HW
2
 
P-value 
Without BF
3
 
Adjustment 
With BF 
Adjustment 
Without BF 
Adjustment 
With BF 
Adjustment 
Without BF 
Adjustment 
With BF 
Adjustment 
rs925946 BDNF Chr11 
T T 
0.85 
0.3973 0.1508 0.8885 0.7194 0.2776 0.4735 
0.355 0.222 
rs8057044 FTO Chr16 
G A 
0.51 
0.7378 0.8398 0.5297 0.5076 0.4651 0.4172 
0.461 0.483 
rs7799039 LEP Chr7 
A A 
0.29 
0.0696 0.0141 0.5019 0.3232 0.7675 0.6885 
0.317 0.323 
rs1137101 LEPR Chr1 
A G 
0.83 
0.9080 0.7981 0.7879 0.9191 0.5540 0.5679 
0.482 0.475 
rs17782313 MC4R Chr18 
C C 
0.87 
0.0376 0.0213 0.1799 0.1060 0.5854 0.6486 
0.259 0.266 
rs6235 PCSK1 Chr5 
C C 
0.18 
0.3094 0.1417 0.1329 0.0490 0.0967 0.0874 
0.278 0.294 
rs934778 POMC Chr2 
C C 
0.97 
0.7679 0.2084 0.5517 0.1033 0.4641 0.1848 
0.384 0.319 
rs2272382 TUB Chr11 
A A 
0.9 
0.4831 0.1295 0.4439 0.3521 0.5387 0.5004 
0.378 0.313 
1
. MAF  minor allele frequency; 
2
. HW Hardy–Weinberg equilibrium; 3. BF  breastfeeding length as three categories (never been breastfed; 
breastfed, but less than 6 months; breastfed for 6 months or more) 
Table 3. Basic information of the selected SNPs and their associations with the HAZ, WAZ and BMIZ.  
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CHAPTER 4 
BRIEF REPORT: Association between Genetic Profile, Obesity Related Phenotypes 
and Satiety Appetite Control 
Introduction 
A strong genetic influence has been shown on the satiety and appetite control in the 
children (1,2). Children‘s Eating Behavior Questionnaire (CEBQ) is the most widely used 
validated questionnaire to measure appetite for children 3 years old or above (3,4).  
Previously, we selected and genotyped eight SNPs in genes that have been shown to be 
associated with satiety and appetite control in the hypothalamus. The purpose of this study is to 
investigate the association between the genetic profile and the satiety regulation, and between 
satiety regulation and obesity related phenotypes.  
 
Subjects and Methods 
Forty nine questions from the section H (Emotional Regulation Section) of the STRONG 
Kids wave 1a survey, and four clusters (cluster 4, 6, 10, and 11) derived from these question 
were used for this association study (Appendix D).  
Genetic analyses were performed using SAS 9.2 (SAS Institute Inc., Cary, NC, USA). 
Associations between the genetic variations and the clusters and questions were tested by general 
linear models (GLM); linkage between clusters and questions and obesity related phenotypes 
were estimated using the REG procedure of SAS, where BMI was adjusted by both age and sex 
of the child.  
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Results 
Among the 19 clusters derived from questions in section H, we were particularly 
interested in four clusters, which may be related to satiety and appetite control: cluster 4 
(Emotional Regulation), cluster 6 (Food as Reward), cluster 10 (Restriction for Health) and 
cluster 11 (Restriction for Weight Control). Out of the 383 participants with complete 
information on these clusters, we have genotype information for 125 Caucasian children.  
Association between the Genetic Variations and the Clusters and Questions 
Question seven in the survey is phrased as -- when this child gets fussy, is giving him/her 
something to eat or drink the first thing you do? That is also one of the three questions in cluster 
4. The responses of question seven (applying a 5-point scale) was significantly linked with 
rs925946 (P=0.0317). The significance of the association remains after adding the breastfeeding 
length as a covariate into the model (P=0.0393). No other association has been found between 
the other genetic variations and the clusters and questions investigated in this cohort.  
Association between the Clusters and Questions and the Obesity Related Phenotypes 
Regression analysis, adjusting for age and sex revealed that responses of ‗Restriction for 
Weight Control‘ (cluster 11) were significantly associated with BMI (P=0.049). ‗Restriction for 
Health‘ (cluster 10) showed a borderline significant association with CDC weight-for-age z-
score (P=0.0567).  
 
Discussion and Future Directions 
We were able to detect some associations in this small cohort. Our result suggested that a 
genetic variation in the BDNF gene (rs925946) was linked with emotion regulation by food. It is 
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consistent with a previous study that showed variations in the BDNF gene were associated with 
satiety, appetite control and regulation of energy metabolism in children (5). Our results also 
indicated that parents are more likely to restrict food consumption in the group of children with 
higher BMI and weight-for-age z-score.  
In our survey, the questions and clusters in section H were originally designed to study 
the impact of emotional eating for obesity development. The questions are related to satiety and 
appetite control, but not direct or specific. This may explain the reason why we were not able to 
detect the strong association either between the genetic markers selected and satiety control, or 
between satiety control and obesity related phenotypes. Questions targeting more specifically at 
satiety and appetite control based on the CEBQ could be added to the follow-up surveys, in order 
to get more in-depth information about children‘s satiety and appetite control.  
 
Literature Cited 
(1) Fisher JO, Birch LL. Eating in the absence of hunger and overweight in girls from 5 to 7 y of 
age. Am J Clin Nutr 2002 Jul;76(1):226-231.  
(2) Jansen A, Theunissen N, Slechten K, Nederkoorn C, Boon B, Mulkens S, et al. Overweight 
children overeat after exposure to food cues. Eat Behav 2003 Aug;4(2):197-209.  
(3) Carnell S, Wardle J. Measuring behavioural susceptibility to obesity: validation of the child 
eating behaviour questionnaire. Appetite 2007 Jan;48(1):104-113.  
(4) Wardle J, Guthrie CA, Sanderson S, Rapoport L. Development of the Children's Eating 
Behaviour Questionnaire. J Child Psychol Psychiatry 2001 Oct;42(7):963-970.  
(5) den Hoed M, Ekelund U, Brage S, Grontved A, Zhao JH, Sharp SJ, et al. Genetic 
susceptibility to obesity and related traits in childhood and adolescence: influence of loci 
identified by genome-wide association studies. Diabetes 2010 Nov;59(11):2980-2988.  
 
56 
 
CHAPTER 5 
FUTURE DIRECTIONS 
 
Further cooperation with other labs should be directed towards testing our weighted risks 
in other cohort or testing the weighted risks generated from other cohorts in our population.  
Some samples failed to be genotyped and are listed in Table A.8 in Appendix A. In 
addition to obtaining the genotypes for the 11 samples that we did not get the genotype at the 
first time for the SNPs rs925946, rs1137101, and rs8057044, we also need to sequence those 
samples that repeatedly failed in order to discover the reason of the failure. A second saliva 
sample of some individuals where low quality gDNA was obtained should be requested. It is 
possible that some other samples might have failed to be genotyped because of existence of copy 
number variations.  
For the questionnaire regarding to satiety and appetite control, questions more 
specifically based on the CEBQ could be added to the follow-up surveys, in order to get more in-
depth information about children‘s satiety and appetite control.  
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APPENDIX A  
ADDITIONAL RESULTS 
 
 
Table A.1. Descriptive characteristics of the STRONG kids Cohort (n=354) 
                
  Variable Mean 95% CI     
  Weight (kg) 15.6 15.4 15.9     
  Height (cm) 97.7 97.0 98.3     
  BMI (kg/m2) 16.3 16.2 16.5     
  BMIPCT(cdc) 61.1 58.3 63.8 
 
  
               
Variable 
CDC WHO 
P-value Mean 95% CL Mean 95% CL 
age 40.30 39.500 41.10 39.80 39.00 40.60 0.39 
WAZ 0.33 0.23 0.43 0.38 0.28 0.48 0.45 
HAZ 0.17 0.06 0.27 -0.05 -0.16 0.05 0.01 
WHZ 0.33 0.24 0.43 0.59 0.50 0.68 <0.0001 
BMIZ 0.36 0.26 0.45 0.61 0.52 0.70 0.0002 
 
Table A.1. The general descriptive data for the whole STRONG Kids cohort 1 (n=354). The BMI 
percentile for age is 61.0 + 26.6 in the cohort. HAZ, WHZ and BMIZ are significantly different 
between CDC and WHO standards.  
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Table A.2. Descriptive Data between Male and Female (N=354) 
    Male (n=182)   Female (n=172)   P-
value Variables 
 
Mean 
Std 
Dev 
Std Error 
Lower 
95%Cl 
Upper 
95%Cl 
 
Mean 
Std 
Dev 
Std Error 
Lower 
95%Cl 
Upper 
95%Cl 
 Weight 
 
15.74 2.15 0.16 15.43 16.05 
 
15.51 2.51 0.19 15.13 15.88 
 
0.35 
Height 
 
97.66 6.38 0.47 96.73 98.59 
 
97.63 6.68 0.51 96.63 98.64 
 
0.97 
CDCage (mo.) 
 
40.07 7.53 0.56 38.96 41.17 
 
40.61 7.77 0.59 39.44 41.78 
 
0.50 
BMI 
 
16.47 1.26 0.09 16.29 16.66 
 
16.19 1.30 0.10 15.99 16.38 
 
0.04 
BMIPCT 
 
61.07 26.48 1.96 57.20 64.95 
 
60.97 26.73 2.04 56.95 65.00 
 
0.97 
CDCWAZ 
 
0.33 0.99 0.07 0.18 0.47 
 
0.32 0.94 0.07 0.18 0.47 
 
0.96 
CDCHAZ 
 
0.06 1.05 0.08 -0.09 0.22 
 
0.27 0.94 0.07 0.13 0.42 
 
0.05 
CDCWHZ 
 
0.38 0.88 0.07 0.25 0.51 
 
0.28 0.93 0.07 0.14 0.42 
 
0.32 
CDCBMIZ 
 
0.38 0.90 0.07 0.24 0.51 
 
0.34 0.94 0.07 0.19 0.48 
 
0.68 
WHOage (mo.) 
 
39.59 7.47 0.55 38.50 40.69 
 
40.10 7.80 0.59 38.93 41.28 
 
0.53 
WHO_BMI 
 
16.47 1.26 0.09 16.29 16.66 
 
16.19 1.30 0.10 15.99 16.38 
 
0.04 
WHOWAZ 
 
0.39 0.96 0.07 0.25 0.53 
 
0.38 0.90 0.07 0.24 0.51 
 
0.93 
WHOHAZ 
 
-0.13 1.09 0.08 -0.28 0.03 
 
0.02 0.98 0.07 -0.13 0.17 
 
0.18 
WHOWHZ 
 
0.66 0.87 0.06 0.54 0.79 
 
0.51 0.86 0.07 0.38 0.64 
 
0.10 
WHOBMIZ   0.68 0.87 0.06 0.56 0.81   0.53 0.88 0.07 0.40 0.66   0.10 
 
Table A.2. Except the absolute value of BMI, there is no significant difference in any phenotype measurement between male and 
female. Consider the growth difference at this age (2-5 years of age), it is expected that boys‘ BMI absolute value can be higher than 
girls of the same age.  
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Table A.3. Descriptive Data between Children with Different Length of Breastfeeding 
Variables 
 
No BF (n=80) 
 
BF but < 6 mo. (n=123) 
 
BF > 6 mo. (n=151) 
 
P-
value 
 
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl 
 
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl 
 
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl 
 
 
Weight 
 
15.81 2.60 0.29 15.23 16.39 
 
15.75 2.16 0.19 15.36 16.14 
 
15.43 2.31 0.19 15.06 15.80 
 
0.386 
Height 
 
97.59 7.18 0.80 95.99 99.19 
 
97.67 6.44 0.58 96.53 98.82 
 
97.65 6.25 0.51 96.65 98.66 
 
0.996 
CDCage(mo.) 
 
40.25 7.85 0.88 38.50 42.00 
 
39.81 7.73 0.70 38.43 41.19 
 
40.79 7.47 0.61 39.59 42.00 
 
0.569 
BMI 
 
16.50 1.08 0.12 16.26 16.75 
 
16.48 1.37 0.12 16.24 16.72 
 
16.12 1.29 0.11 15.92 16.33 
 
0.030 
BMIPCT 
 
65.85 23.30 2.61 60.66 71.03 
 
63.53 26.59 2.40 58.79 68.28 
 
56.43 27.58 2.24 51.99 60.86 
 
0.016 
CDCWAZ 
 
0.40 0.99 0.11 0.18 0.62 
 
0.45 0.94 0.08 0.29 0.62 
 
0.19 0.97 0.08 0.03 0.34 
 
0.056 
CDCHAZ 
 
0.16 1.12 0.13 -0.09 0.41 
 
0.25 1.01 0.09 0.07 0.43 
 
0.10 0.94 0.08 -0.05 0.25 
 
0.462 
CDCWHZ 
 
0.46 0.77 0.09 0.28 0.63 
 
0.43 0.92 0.08 0.27 0.60 
 
0.18 0.94 0.08 0.03 0.33 
 
0.026 
CDCBMIZ 
 
0.50 0.78 0.09 0.33 0.68 
 
0.44 0.93 0.08 0.27 0.61 
 
0.21 0.96 0.08 0.06 0.36 
 
0.031 
WHOage(mo.) 
 
39.81 7.88 0.88 38.06 41.57 
 
39.28 7.71 0.70 37.90 40.65 
 
40.32 7.44 0.61 39.12 41.51 
 
0.532 
WHO_BMI 
 
16.50 1.08 0.12 16.26 16.75 
 
16.48 1.37 0.12 16.24 16.72 
 
16.12 1.29 0.11 15.92 16.33 
 
0.030 
WHOWAZ 
 
0.45 0.95 0.11 0.24 0.67 
 
0.51 0.91 0.08 0.35 0.67 
 
0.24 0.92 0.07 0.09 0.39 
 
0.039 
WHOHAZ 
 
-0.06 1.16 0.13 -0.32 0.19 
 
0.05 1.04 0.09 -0.14 0.23 
 
-0.13 0.97 0.08 -0.29 0.02 
 
0.353 
WHOWHZ 
 
0.71 0.75 0.08 0.54 0.87 
 
0.69 0.90 0.08 0.53 0.85 
 
0.45 0.88 0.07 0.30 0.59 
 
0.027 
WHOBMIZ   0.74 0.74 0.08 0.58 0.91   0.70 0.90 0.08 0.54 0.86   0.47 0.90 0.07 0.32 0.61   0.027 
 
Table A.3. In this whole cohort including different ethnicities, length of breastfeeding showed significant association with BMI absolute value, 
BMI percentile for the age, CDC WAZ, HAZ, WHZ, BMIZ, WHO WAZ, WHZ and WHO BMIZ.  CDC WAZ also shows borderline 
significance. Almost all the quantitative measurements for obesity were affected by the length of breastfeeding.  
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Table A.4. Descriptive Data Among Different Ethnicities  (N=354) 
Variables 
  African American (n=41)   Caucasian (n=226)   Others (n=86) *   
P-value 
 
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl 
 
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl 
 
Mean Std Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl 
 
Weight 
 
16.40 2.87 0.45 15.49 17.30 
 
15.59 2.29 0.15 15.29 15.89 
 
15.34 2.10 0.23 14.89 15.79 
 
0.055 
Height 
 
99.43 7.97 1.24 96.91 101.94 
 
97.51 6.46 0.43 96.66 98.35 
 
97.18 5.83 0.63 95.93 98.43 
 
0.166 
CDCage(mo.) 
 
41.17 7.94 1.24 38.67 43.68 
 
40.35 7.67 0.51 39.34 41.36 
 
39.97 7.47 0.81 38.36 41.57 
 
0.709 
BMI 
 
16.50 1.55 0.24 16.01 16.99 
 
16.35 1.30 0.09 16.18 16.52 
 
16.19 1.07 0.12 15.96 16.42 
 
0.409 
BMIPCT 
 
63.16 25.08 3.92 55.24 71.08 
 
61.36 27.29 1.82 57.79 64.94 
 
58.79 25.40 2.74 53.34 64.23 
 
0.636 
CDCWAZ 
 
0.58 1.31 0.20 0.16 0.99 
 
0.31 0.90 0.06 0.19 0.43 
 
0.24 0.94 0.10 0.04 0.44 
 
0.171 
CDCHAZ 
 
0.47 1.39 0.22 0.03 0.91 
 
0.12 0.92 0.06 0.00 0.24 
 
0.12 0.98 0.11 -0.09 0.33 
 
0.112 
CDCWHZ 
 
0.46 1.00 0.16 0.14 0.77 
 
0.34 0.93 0.06 0.21 0.46 
 
0.25 0.80 0.09 0.08 0.42 
 
0.464 
CDCBMIZ 
 
0.49 0.94 0.15 0.20 0.79 
 
0.36 0.95 0.06 0.24 0.49 
 
0.27 0.81 0.09 0.10 0.44 
 
0.444 
WHOage(mo.) 
 
40.61 7.94 1.24 38.10 43.11 
 
39.88 7.66 0.51 38.87 40.88 
 
39.47 7.46 0.80 37.87 41.06 
 
0.732 
WHO_BMI 
 
16.50 1.55 0.24 16.01 16.99 
 
16.35 1.30 0.09 16.18 16.52 
 
16.19 1.07 0.12 15.96 16.42 
 
0.409 
WHOWAZ 
 
0.65 1.28 0.20 0.25 1.05 
 
0.36 0.86 0.06 0.25 0.47 
 
0.29 0.90 0.10 0.10 0.48 
 
0.116 
WHOHAZ 
 
0.28 1.39 0.22 -0.16 0.72 
 
-0.10 0.95 0.06 -0.23 0.02 
 
-0.10 1.04 0.11 -0.32 0.13 
 
0.090 
WHOWHZ 
 
0.70 1.01 0.16 0.38 1.02 
 
0.60 0.88 0.06 0.48 0.71 
 
0.51 0.75 0.08 0.34 0.67 
 
0.484 
WHOBMIZ   0.73 0.98 0.15 0.42 1.04   0.62 0.90 0.06 0.50 0.74   0.52 0.75 0.08 0.36 0.68   0.421 
* Others included American Indian or Alaska Native, Native Hawaiian or other Pacific Islander, Asian and mixed ethnicities.   
Table A.4. Except the absolute value of weight showed borderline significant difference, no significant discrepancy was detected in any of the 
method of measurement for obesity among the different ethnicity groups.  
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Table A.5. Descriptive Data Between Male and Female (N=128) 
Variable 
  Male (n= 64)   Female (n= 64)   
P-
value 
 
Mean Std Dev Std Error 
Lower 
95%Cl 
Upper 
95%Cl  
Mean Std Dev Std Error 
Lower 
95%Cl 
Upper 
95%Cl  
Weight 
 
15.93 1.97 0.25 15.43 16.42 
 
15.23 2.01 0.25 14.73 15.74 
 
0.05 
Height 
 
97.74 5.83 0.73 96.29 99.2 
 
96.39 5.61 0.70 94.99 97.79 
 
0.18 
BMI 
 
16.64 1.10 0.14 16.37 16.92 
 
16.37 1.29 0.16 16.05 16.69 
 
0.19 
CDC 
age 
 
40.47 7.73 0.97 38.54 42.4 
 
39.27 6.79 0.85 37.57 40.96 
 
0.35 
BMIPCT 
 
67.14 24.61 3.08 60.99 73.29 
 
63.44 23.99 3.00 57.45 69.44 
 
0.39 
WAZ 
 
0.42 0.84 0.11 0.21 0.63 
 
0.36 0.86 0.11 0.15 0.58 
 
0.72 
HAZ 
 
0.03 0.92 0.11 -0.20 0.26 
 
0.16 0.9 0.11 -0.06 0.39 
 
0.43 
WHZ 
 
0.53 0.78 0.10 0.34 0.73 
 
0.41 0.82 0.10 0.21 0.62 
 
0.39 
BMIZ   0.54 0.81 0.10 0.34 0.74   0.45 0.82 0.10 0.25 0.66   0.55 
 
Table A.5. There is no significant difference in weight, height, age, BMI, BMI percentile and CDC z-scores between male and female children 
in the genotyped Caucasian cohort (n=128).  
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Table A.6.1. Descriptive Data among Groups with Different Length of Breastfeeding (N=128) 
Variable 
  No BF* (n= 31)   BF but < 6m (n= 43)   BF > 6m (n= 54)   
P-
value 
 
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl  
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl  
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl  
Weight 
 
16.07 2.68 0.48 15.08 17.05 
 
15.39 1.53 0.23 14.92 15.86 
 
15.45 1.90 0.26 14.94 15.97 
 
0.30 
Height 
 
98.12 6.93 1.24 95.58 100.66 
 
96.41 5.10 0.78 94.84 97.98 
 
96.98 5.49 0.75 95.48 98.48 
 
0.45 
BMI 
 
16.60 1.23 0.22 16.15 17.05 
 
16.56 1.11 0.17 16.22 16.90 
 
16.41 1.27 0.17 16.06 16.76 
 
0.74 
CDC 
age 
 
41.03 6.89 1.24 38.51 43.56 
 
38.44 6.87 1.05 36.33 40.56 
 
40.33 7.73 1.05 38.22 42.44 
 
0.26 
BMIPCT 
 
67.53 23.67 4.25 58.85 76.21 
 
66.68 22.44 3.42 59.78 73.59 
 
62.90 26.19 3.56 55.75 70.05 
 
0.63 
WAZ 
 
0.48 0.93 0.17 0.14 0.82 
 
0.44 0.71 0.11 0.23 0.66 
 
0.29 0.91 0.12 0.05 0.54 
 
0.55 
HAZ 
 
0.17 1.15 0.21 -0.25 0.59 
 
0.14 0.8 0.12 -0.11 0.38 
 
0.03 0.85 0.12 -0.21 0.26 
 
0.75 
WHZ 
 
0.54 0.77 0.14 0.26 0.83 
 
0.51 0.71 0.11 0.29 0.73 
 
0.40 0.88 0.12 0.16 0.64 
 
0.69 
BMIZ   0.60 0.83 0.15 0.29 0.90   0.51 0.74 0.11 0.28 0.74   0.43 0.87 0.12 0.20 0.67   0.68 
*BF: breastfeeding 
Table A.6.1. There is no significant difference in weight, height, age, BMI, BMI percentile, and CDC z-scores among the three groups with 
different length of breastfeeding in the Caucasian cohort (n=128).  
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Table A.6.2. Descriptive Data among Groups with Different Length of Breastfeeding (Two groups, N=128) 
Variable 
  No BF or BF but < 6m (n= 74)   BF > 6m (n= 54)   
P-
value 
 
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl  
Mean 
Std 
Dev 
Std 
Error 
Lower 
95%Cl 
Upper 
95%Cl  
Weight 
 
15.67 2.10 0.24 15.19 16.16 
 
15.45 1.9 0.26 14.94 15.97 
 
0.55 
Height 
 
97.13 5.95 0.69 95.75 98.51 
 
96.98 5.49 0.75 95.48 98.48 
 
0.88 
BMI 
 
16.58 1.15 0.13 16.31 16.84 
 
16.41 1.27 0.17 16.06 16.76 
 
0.44 
CDC 
age 
 
39.53 6.95 0.81 37.92 41.14 
 
40.33 7.73 1.05 38.22 42.44 
 
0.54 
BMIPCT 
 
67.04 22.8 2.65 61.75 72.32 
 
62.9 26.19 3.56 55.75 70.05 
 
0.34 
WAZ 
 
0.46 0.80 0.09 0.27 0.65 
 
0.29 0.91 0.12 0.05 0.54 
 
0.28 
HAZ 
 
0.15 0.95 0.11 -0.07 0.37 
 
0.03 0.85 0.12 -0.21 0.26 
 
0.45 
WHZ 
 
0.52 0.73 0.09 0.35 0.69 
 
0.4 0.88 0.12 0.16 0.64 
 
0.40 
BMIZ   0.55 0.77 0.09 0.37 0.72   0.43 0.87 0.12 0.20 0.67   0.45 
 
Table A.6.2. We separated the breastfeeding length as not meeting the AAP recommendation (never breastfeeding or breastfeeding but less 
than 6 months) from meeting the AAP recommendation (breastfeeding more than 6 months). No significant difference was found between 
these two groups in this Caucasian cohort.  
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Table A.7. Genetic Association for Single SNPs* 
   
SNP (M 1) 
 
SNP&BF no interaction (M 2) 
 
SNP&BF&interaction (M 3) 
    
 
Model&SNP 
 
Model SNP BF 
 
Model SNP BFge6m SNP*BFge6m 
rs925946 BMIPCT  
 
0.213 
 
0.294 0.246 0.428 
 
0.302 0.420 0.336 0.311 
 
CDCWAZ  
 
0.889 
 
0.749 0.889 0.324 
 
0.226 0.719 0.382 0.060 
 
CDCHAZ  
 
0.397 
 
0.508 0.369 0.489 
 
0.145 0.151 0.706 0.054 
 
CDCWHZ  
 
0.386 
 
0.475 0.428 0.438 
 
0.489 0.612 0.377 0.382 
  CDCBMIZ  
 
0.278   0.359 0.316 0.416 
 
0.443 0.474 0.403 0.456 
rs925946_2G BMIPCT  
 
0.776 
 
0.614 0.784 0.345 
 
0.776 0.856 0.484 0.715 
 
CDCWAZ  
 
0.626 
 
0.545 0.634 0.324 
 
0.751 0.646 0.699 0.994 
 
CDCHAZ  
 
0.858 
 
0.840 0.863 0.574 
 
0.923 0.801 0.905 0.716 
 
CDCWHZ  
 
0.858 
 
0.589 0.614 0.374 
 
0.765 0.677 0.528 0.754 
  CDCBMIZ  
 
0.616   0.562 0.623 0.344 
 
0.751 0.675 0.553 0.804 
rs1137101 BMIPCT  
 
0.536 
 
0.586 0.550 0.408 
 
0.651 0.590 0.630 0.500 
 
CDCWAZ  
 
0.788 
 
0.737 0.832 0.376 
 
0.573 0.919 0.482 0.279 
 
CDCHAZ  
 
0.908 
 
0.920 0.935 0.585 
 
0.641 0.798 0.487 0.240 
 
CDCWHZ  
 
0.624 
 
0.675 0.638 0.443 
 
0.675 0.654 0.712 0.444 
  CDCBMIZ  
 
0.550   0.598 0.552 0.404 
 
0.627 0.568 0.668 0.451 
rs1137101_2A BMIPCT  
 
0.846 
 
0.690 0.946 0.403 
 
0.542 0.927 0.982 0.237 
 
CDCWAZ  
 
0.667 
 
0.610 0.769 0.371 
 
0.435 0.749 0.996 0.189 
 
CDCHAZ  
 
0.689 
 
0.798 0.754 0.585 
 
0.815 0.744 0.954 0.488 
 
CDCWHZ  
 
0.870 
 
0.729 0.963 0.438 
 
0.515 0.943 0.933 0.200 
  CDCBMIZ  
 
0.954   0.698 0.856 0.398 
 
0.506 0.875 0.985 0.205 
rs8057044 BMIPCT  
 
0.563 
 
0.571 0.502 0.355 
 
0.789 0.537 0.297 0.811 
 
CDCWAZ  
 
0.530 
 
0.506 0.467 0.304 
 
0.634 0.508 0.577 0.576 
 
CDCHAZ  
 
0.738 
 
0.801 0.718 0.532 
 
0.531 0.840 0.936 0.213 
 
CDCWHZ  
 
0.494 
 
0.535 0.435 0.379 
 
0.823 0.444 0.406 0.990 
  CDCBMIZ  
 
0.465   0.488 0.402 0.344 
 
0.773 0.417 0.320 0.945 
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Table A.7. Genetic Association for Single SNPs Continued 
   
SNP 
 
SNP&BF no interaction 
 
SNP&BF&interaction 
    
 
Model&SNP 
 
Model SNP BF 
 
Model SNP BFge6m SNP*BFge6m 
rs8057044_2G BMIPCT  
 
0.815 
 
0.716 0.837 0.435 
 
0.879 0.859 0.483 0.920 
 
CDCWAZ  
 
0.383 
 
0.443 0.366 0.353 
 
0.607 0.439 0.609 0.644 
 
CDCHAZ  
 
0.441 
 
0.619 0.431 0.545 
 
0.627 0.570 0.994 0.376 
 
CDCWHZ  
 
0.619 
 
0.675 0.602 0.463 
 
0.853 0.609 0.536 0.982 
  CDCBMIZ  
 
0.856   0.725 0.835 0.436 
 
0.865 0.786 0.415 0.758 
rs6235 BMIPCT  
 
0.095 
 
0.123 0.081 0.299 
 
0.320 0.096 0.303 0.935 
 
CDCWAZ  
 
0.133 
 
0.161 0.133 0.289 
 
0.099 0.049 0.802 0.129 
 
CDCHAZ  
 
0.309 
 
0.414 0.340 0.472 
 
0.132 0.142 0.952 0.062 
 
CDCWHZ  
 
0.124 
 
0.171 0.112 0.355 
 
0.346 0.092 0.645 0.730 
  CDCBMIZ  
 
0.097   0.131 0.085 0.324 
 
0.339 0.087 0.464 0.956 
rs6235_2G BMIPCT  
 
0.358 
 
0.401 0.294 0.322 
 
0.583 0.278 0.381 0.719 
 
CDCWAZ  
 
0.723 
 
0.562 0.835 0.312 
 
0.703 0.781 0.848 0.610 
 
CDCHAZ  
 
0.311 
 
0.470 0.366 0.486 
 
0.658 0.349 0.873 0.753 
 
CDCWHZ  
 
0.544 
 
0.565 0.470 0.380 
 
0.754 0.497 0.744 0.808 
  CDCBMIZ  
 
0.498   0.512 0.422 0.349 
 
0.721 0.427 0.564 0.979 
rs934778 BMIPCT  
 
0.470 
 
0.458 0.407 0.297 
 
0.509 0.184 0.105 0.431 
 
CDCWAZ  
 
0.552 
 
0.470 0.486 0.249 
 
0.283 0.103 0.031 0.158 
 
CDCHAZ  
 
0.768 
 
0.747 0.716 0.405 
 
0.468 0.208 0.061 0.189 
 
CDCWHZ  
 
0.563 
 
0.554 0.496 0.333 
 
0.598 0.242 0.126 0.455 
  CDCBMIZ  
 
0.464   0.451 0.394 0.295 
 
0.506 0.185 0.111 0.433 
rs934778_2T BMIPCT  
 
0.236 
 
0.274 0.181 0.276 
 
0.244 0.069 0.104 0.210 
 
CDCWAZ  
 
0.308 
 
0.286 0.233 0.226 
 
0.106 0.035 0.025 0.058 
 
CDCHAZ  
 
0.486 
 
0.541 0.414 0.389 
 
0.212 0.079 0.046 0.071 
 
CDCWHZ  
 
0.295 
 
0.351 0.236 0.318 
 
0.316 0.095 0.125 0.230 
  CDCBMIZ  
 
0.223   0.266 0.172 0.281 
 
0.249 0.069 0.113 0.225 
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Table A.7. Genetic Association for Single SNPs Continued 
   
SNP 
 
SNP&BF no interaction 
 
SNP&BF&interaction 
    
 
Model&SNP 
 
Model SNP BF 
 
Model SNP BFge6m SNP*BFge6m 
rs2272382 BMIPCT  
 
0.640 
 
0.568 0.623 0.289 
 
0.765 0.571 0.199 0.754 
 
CDCWAZ  
 
0.444 
 
0.428 0.470 0.285 
 
0.177 0.352 0.864 0.089 
 
CDCHAZ  
 
0.483 
 
0.608 0.518 0.537 
 
0.014 0.130 0.285 0.002 
 
CDCWHZ  
 
0.542 
 
0.533 0.539 0.326 
 
0.823 0.550 0.442 0.996 
  CDCBMIZ  
 
0.539   0.501 0.532 0.290 
 
0.739 0.500 0.255 0.818 
rs2272382_2G BMIPCT  
 
0.967 
 
0.579 0.893 0.297 
 
0.647 0.653 0.227 0.453 
 
CDCWAZ  
 
0.398 
 
0.402 0.455 0.293 
 
0.285 0.198 0.580 0.161 
 
CDCHAZ  
 
0.233 
 
0.408 0.259 0.538 
 
0.092 0.049 0.155 0.032 
 
CDCWHZ  
 
0.832 
 
0.615 0.900 0.336 
 
0.808 0.927 0.559 0.963 
  CDCBMIZ  
 
0.883   0.577 0.957 0.300 
 
0.715 0.861 0.314 0.609 
rs7799039 BMIPCT  
 
0.456 
 
0.490 0.472 0.357 
 
0.728 0.446 0.788 0.813 
 
CDCWAZ  
 
0.502 
 
0.288 0.415 0.124 
 
0.311 0.323 0.173 0.334 
 
CDCHAZ  
 
0.070 
 
0.065 0.052 0.169 
 
0.045 0.014 0.063 0.127 
 
CDCWHZ  
 
0.894 
 
0.763 0.926 0.335 
 
0.883 0.866 0.761 0.745 
  CDCBMIZ  
 
0.768   0.721 0.832 0.371 
 
0.832 0.689 0.906 0.674 
rs7799039_2G BMIPCT  
 
0.555 
 
0.588 0.700 0.398 
 
0.721 0.523 0.994 0.602 
 
CDCWAZ  
 
0.520 
 
0.224 0.322 0.109 
 
0.366 0.311 0.221 0.660 
 
CDCHAZ  
 
0.184 
 
0.137 0.103 0.138 
 
0.130 0.039 0.060 0.196 
 
CDCWHZ  
 
0.713 
 
0.597 0.884 0.344 
 
0.729 0.641 0.949 0.603 
  CDCBMIZ  
 
0.543   0.569 0.691 0.385 
 
0.650 0.432 0.884 0.472 
rs17782313 BMIPCT  
 
0.566 
 
0.629 0.514 0.439 
 
0.847 0.660 0.838 0.866 
 
CDCWAZ  
 
0.180 
 
0.182 0.147 0.230 
 
0.314 0.106 0.360 0.582 
 
CDCHAZ  
 
0.038 
 
0.053 0.032 0.288 
 
0.082 0.021 0.239 0.344 
 
CDCWHZ  
 
0.598 
 
0.654 0.545 0.441 
 
0.869 0.645 0.783 0.887 
  CDCBMIZ  
 
0.585   0.641 0.532 0.435 
 
0.865 0.649 0.775 0.898 
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Table A.7. Genetic Association for Single SNPs Continued 
   
SNP 
 
SNP&BF no interaction 
 
SNP&BF&interaction 
    
 
Model&SNP 
 
Model SNP BF 
 
Model SNP BFge6m SNP*BFge6m 
rs17782313_2T BMIPCT  
 
0.350 
 
0.496 0.318 0.466 
 
0.672 0.516 0.995 0.704 
 
CDCWAZ  
 
0.900 
 
0.585 0.823 0.305 
 
0.777 0.775 0.530 0.855 
 
CDCHAZ  
 
0.552 
 
0.596 0.609 0.410 
 
0.703 0.912 0.356 0.538 
 
CDCWHZ  
 
0.408 
 
0.548 0.372 0.472 
 
0.734 0.543 0.940 0.777 
  CDCBMIZ    0.374   0.515 0.341 0.463   0.706 0.507 0.931 0.781 
*Shown as P-values. 
Table A.7. Genetic association studies between each SNP and BMI percentile, CDC z-scores.  ‗Model&SNP‘ refers to test with SNP itself, 
without any covariate; ‗SNP&BF no interaction‘ refers to the model with breastfeeding as a covariate without interaction between SNP and 
breastfeeding length; ‗SNP&BF&interaction‘ refers to the model with breastfeeding and also with the interactions between SNP and 
breastfeeding length.  Significant results are boxed, bolded and italicized. Borderline significant P-values are bolded. SNP_2 means to test the 
difference with or without this specific allele.  
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Table A.8. Failed Samples and Failure Rate for Each SNP (N=131) 
ID failed rs925946 rs1137101 rs8057044 rs6235 rs934778 rs2272382 rs7799039 rs17782313 
1 122014 122014 211012 230006 113028 229009 116006 122016 
2 101017 101017 122014 113028   114005 104012 117002 
3 231005 211002 101017       113028 228007 
4 211002 121110 211002       227002 109003 
5 121110 115012 228007         225004 
6 115012 115009 103007         113028 
7 229009 121113 121110           
8 115009 113019 115012           
9 224024 207008 115009           
10 121113 207001 121113           
11 113019 224004 113019           
12 207008   207008           
13 207001   207001           
14 224004   224004           
         No. failed 14 11 14 2 1 2 4 6 
Failure 
rate 0.109 0.086 0.109 0.016 0.008 0.016 0.031 0.047 
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APPENDIX B 
EXPERIMENTAL PROTOCOLS IN THIS STUDY 
 
a. Genomic DNA Extraction 
1. Only personnel trained in blood borne pathogen materials are authorized to perform the DNA 
extraction. Remember saliva samples are partially inactivated as soon as they are collected 
and the recipient vial closes (the closure of the vial releases a salt solution to this effect). This 
process eliminates 98% of the pathogens in biological samples. 
2. Obtain the key to unlock the -80⁰C freezer.  
3. Personnel should wear personal protective equipment (PPE), including NON-LATEX gloves, 
face mask and lab coat before opening the freezer that contains the samples. 
4. Obtain samples to be processed for DNA extraction. Samples are stored in the freezer inside 
of a cardboard box and a sealed plastic bag until processing. Read label of samples to be 
processed. 
5. Samples will be handled in a biosafety cabinet (BSC2) until they are fully disinfected (step 
4.9). 
6. Incubate at 50 ⁰C for 1 hour. 
7. Once the sample is completely thawed, mix the Oragene/saliva sample in the Oragene vial by 
inversion and gentle shaking for several seconds.  
8. Transfer the sample (~4ml) to a 15ml graduated centrifuge tube by centrifugation for 15 
minutes at 500 x g. Make sure the sample is cooled to room temperature before adding the 
next reagent. 
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9. Estimate the sample volume by looking at the 15 ml graduated tube. Add 1/25th (4%) volume 
of Oragene-DNA Purifier (Reagent 1) and mix by vortexing for a few seconds. For example: 
SAMPLE volume Oragene-DNA Purifier 
500μl 20μl 
1000μl 40μl 
2000μl 80μl 
4000μl 160μl 
10. Incubate on ice for 8 minutes. 
11. Centrifuge at room temperature for 10 minutes at 3,500 x g (Eppendorf). 
12. Transfer majority of supernatant (90-95%) with a pipette to a fresh 15ml centrifuge tube. Be 
CAREFUL not to transfer any pellet (debris) to the new tube. Discard tube containing pellet 
in biohazard bag 
13. Estimate the sample volume by looking at the 15 ml graduated tube. Add an equal volume of 
room temperature 100% ethanol to the clear supernatant. Mix gently by inversion 10 times. 
14. Allow the sample to stand at room temperature for 10 minutes. 
15. Centrifuge at room temperature for 10 minutes at highest speed possible. (NOTE: At this 
time the procedure could be stop. Store samples at -20⁰C to continue next day. If so, start 
from step 4.15 and centrifuge again). 
16. Remove supernatant and discard in a beaker, it could go to the sink after several samples. Be 
careful, PELLET contains the DNA. 
17. Add 1.0ml (1000µl) of 70% ethanol and mix and rinse the wall well by pipette up and down 
several times. Mix well to remove the excess salt from DNA pellet.  
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18. Centrifuge it for 15 min at 15,000 rpm (highest speed) on the eppendorf centrifuge. Remove 
supernatant carefully and keep your DNA pellet.  
19. Get rid of most of the supernatant and leave a little residual (around 500 µl). Add another 
around 500µl 70% ethanol to balance well. Mix and rinse the wall well by pipette up and 
down several times. Mix well to remove the excess salt from DNA pellet.  
20. Centrifuge it for 15 min at 15,000 rpm (highest speed) on the eppendorf centrifuge. Remove 
supernatant carefully and keep your DNA pellet. Gently swirl and completely remove 
ethanol /let evaporate under the BSL2. BE SURE NO RESIDUAL ALCOHOL REMAINS. 
Depending on environmental humidity, it could take 20 to 30 mins.  
21. Add _ μl of TE buffer and vortex the sample for 30 seconds. NOTE: the amount of TE buffer 
is proportional to the expected DNA; the aim is to keep a stock of 50ng/μl.  
22. Pipette up and down several time using a Wide Orifice Pipet Tip and vortex to ensure the 
pellet is dissolved in the buffer.  
23. Incubate at 50⁰C for 1 hour with occasional vortexing. 
24. Place the tubes for overnight rotation in the revolver sample mixer. 
25. Quantify. Record DNA concentration and label the tube.  
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b. Genomic DNA Quantification 
1. Before leaving the lab, check your samples for residue on the sides of centrifuge tubes. If 
there is residue, vortex and centrifuge your samples for a few seconds. 
2. Before leaving the lab, make sure you have all the items on the Nanodrop check list. 
3. Look for the nanodrop icon on the desktop and click on it. A window will open with 
options, click on nucleic acid. 
4. Before using the blank solution wipe the surface and the lid of the nanodrop with water 
and a kimwipe 
5. Place the 2 µl of the blank onto the center of the surface and close the lid. Make sure to 
type in blank into the ID name before clicking measure. 
6. Before pipetting sample onto the nanodrop, mix the sample using the 20 µl by pressing 
the pipettor up and down. 
7. Wipe the surface with kimwipes  for every sample measured 
8. Make sure to place the sample on the center of the surface. 
9. Use only 2 µl of each sample 
10. Don‘t forget to press measure after every sample.  Measure each sample twice. 
11. Use a different tip for every sample. 
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c. PCR Test for gDNA Extracted 
Sample preparation 
1. Dilute and prepare the samples to the desired concentration 
No. Sample Dilution Volume (µl) Final conc. 
(ng/µl) 
Notes 
1    1  
2          1  
 
2. Mix the following in 1.5ml microcentrifuge tubes 
QIAGEN Mix (3.5mM MgCl2) Final Conc. Per reaction (µl) 14Xreactions(µl) 
Qiagen PCR buffer (10X, 15mM 
MgCl2) 
1X 2  
MgCl2(25mM) 3.5mM total 1.6  
dNTPs (5mM each) 100µM each 0.4  
F-primer (10µM)   ___ 120nM 0.24  
R-primer (10µM)   ___ 120nM 0.24  
Taq (5U/µl)  0.08  
dH2O  5.44  
Total  10  
 
3. Mix reaction mixtures and spin down.  
4. Add 4µl template, 1µl water to each clean 0.2ml PCR tube.  
5. Aliquot 5µl of each mix to the PCR tubes.  
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6. Mix and spin down.  
7. PCR (Start program & wait until block is ~80˚C before adding tubes to machine) 
                95C                    2 min 
   35         95C                    30 sec 
 cycles     61.5C                 30 sec   
                 72C                    1.5 min 
                 Repeat 34 cycles 
     72C                     5 min 
      Hold 4C 
 
Agarose gel (1.5%) prep 
1. Set up the gel tray with comb.  
2. Weigh agarose: 0.15g/10ml tray volume. Add to flask.  
3. Measure 1X TAE buffer in amount equal to tray volume. Add to flask.  
 Volume of gel (ml) 
 35 50 75 100 
Agarose (g) 0.525 0.75 1.125 1.5 
TAE (ml) 35 50 75 100 
 
4. Microwave flask 30 sec. Swirl well. Repeat microwaving (~10 sec at a time) and swirling 
until all agarose is dissolved. Cool on counter for 1-3 minutes, until 50-60˚C.  
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5. Add Ethidium Bromide:  0.4 µl/ml.  Swirl. (Example: 50ml gel needs 2 µl ethidium 
bromide).  
 Volume of gel (ml) 
 35 50 75 100 
EB (µl) 1.4 2.0 3.0 4.0 
6. Pour solution into gel tray. Allow it to set 20-30 min. To save gel for later, cover with 1X 
TAE buffer and place in refrigerator.  
Sample preparation and run 
7. Place prepared gel in electrophoresis system, wells on the negative side.  
8. Add approximately 1 µl 10X gel loading buffer to each PCR tube.  
9. Mix and add 10 µl samples to each well. Save remaining sample in case gel need to be 
replaced.  
10. Run electrophoresis 100V for 20 minutes.  
Take picture 
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d. Primer Re-suspension/Dilution  
 
Re-suspension 
1. When primers arrive group them together according to SNP set and enter them in the 
SNP primer inventory spreadsheet located at: S:\TeranLab\SNPs\Lab primer inventory 
2. Take all primers to the Pre-PCR area.  Label primers with yellow dot and number 
corresponding with the number given in the spreadsheet. 
3. Centrifuge primers in pico-fuge so that everything falls to the bottom of the tube. 
4. Using filter tips, add the appropriate amount of 1XTE (multiply number of nmols on 
tube by 10).  (Concentrations of primers will be at 100µM) 
5. Example:  If tube reads ―78.5nmol‖ then dispense 78.5 x 10 = 785µL of 1XTE 
6. Vortex primers well. 
7. Allow primers to sit at room temperature in designated room overnight (or the weekend 
if re-suspending on a Friday). 
8. On the following work day, make primer dilution according to procedure shown below 
before storing at –20°C. 
Dilution 
9. Label the appropriate amount of 1.5mL tubes.  (Make sure that labeling is clear for 
everyone to read being certain to include all information for SNP name). 
10. To make 10µM working solution, dispense 900µL of ddH2O in tube and using filter tips 
add 100µL of stock solution. 
11. Vortex tubes well.  Diluted primers are now ready for use in reaction mixes.  Stock tubes 
can now be stored in appropriate stock tube boxes at –20°C. 
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e. Fluorescence Polarization 
Sample preparation 
1.   Dilute and prepare the samples to the desired concentration. Prepare dry DNA (1ng/ul).  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
A                         
B                         
C                         
D                         
E                         
F                         
G                         
H                         
I                         
J                         
K                         
L                         
M                         
N                         
O                         
P                         
 
2. Mix the following in 1.5ml microcentrifuge tubes for primers 
QIAGEN Mix (3.5mM MgCl2) Per reaction (µl) 220 reactions(µl) 
Qiagen PCR buffer (10X, 15mM MgCl2) 1.2 264 
MgCl2(25mM) 0.96 211.2 
dNTPs (2.5mM each) 0.48 105.6 
F-primer (10µM)   0.144 31.68 
R-primer (10µM)    0.144 31.68 
Taq (5U/µl) 0.048 10.56 
dH2O 3.024 876.48 
Total 6 1320 
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3. SAP Aliquot 5µl of each mix to the PCR tubes. 
 Per reaction (µl) 220 reactions (µl) 
ExoSAPit 0.65 143 
dH2O 4.35 957 
Total 5 1100 
 
4. Single Base Pair Extension for primers  
rs Per reaction (µl) 210 reactions(µl) 
dH2O 6.975 1464.75 
Reaction buffer 2 420 
Primer  0.5 105 
Terminator mix 0.5 105 
Thermosequenase 0.025 5.25 
Total 10 2100 
 
 
 
 
 
 
 
 
 
79 
 
f. Preparation of Thermosequenase Reaction Buffer 
To make 10ml reaction buffer (pH=9.5), we need 260mM Tris-HCl, 65mM MgCl2 
1. Weigh 0.31g Tris-base powder (121.14 g/mol) 
2. Weigh 0.06g MgCl2 (95.22 g/mol) 
3. Dissolve with water 
4. Used 2-3 drops 37% HCl to bring the pH down to 9.5 
5. Bring the total volume to 10ml by adding more water 
6. Store in 4 degree if use later 
7. Use syringe and syringe filter to filter the solution to a new tube 
8. Store in -20 degree refrigerator 
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g. Manual for CDC Growth Curve Macro 
For children between 2 and 20 years old, we can calculate both BMI and BMI%. For adults older 
than 20 years, we do not use BMI%. We can calculate adults‘ BMI by the basic BMI calculation 
formula.  
BMI calculated by either CDC or WHO standard are the same. Also, we did not calculate BMI% 
using WHO standard. We calculated the BMI and BMI% using the CDC standard.  
There are two major methods to calculate BMI and BMI% by CDC standards: CDC BMI% excel 
macro or CDC SAS macro. I am showing both methods step by step below.  
CDC BMI% Excel Macro 
1. Prepare your existing dataset. 
There are six columns of information needed: ID, sex, Date of birth, Date of Measurement, 
Height (centimeters) and Weight (kilograms).  
ID Numeric variable                                                                                                                                  
sex Input as m (male) or f (female)   
Date of birth 
and Date of 
Measurement 
Input such as 02/25/2011. If the difference between date of birth and date of 
measurement is less than 24 months or larger than 240 months, the column for 
BMI% will say ‗age error‘.   
Height and 
Weight 
Numeric variable. Pay attention to the units. The column will say ‗wt or ht 
error‘, if they are in the wrong units, 
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2. As soon as you input the complete information for each ID, the BMI and BMI% will show 
automatically in their columns as showed here 
 
3. Copy and paste the BMI and BMI% information.  
 
CDC SAS macro (By doing it this way, we can get z-scores too) 
1. Save the SAS programs to your computer by clicking the links shown below. 
In either case, keep the file names and file extensions as they are — gc-setup.sas and gc-
calculate-BIV.sas. Save them in a location where you can access them from your SAS program. 
Results of 
BMI and 
BMI %tile 
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gc-setup.sas (1k) gc-calculate-BIV.sas (227k) 
Note: some browsers may not allow the downloading of .sas files. Try downloading the zip file 
instead. This contains both files above: SAS_growthchard_files.zip . 
 
2. Prepare your existing dataset. 
Your dataset must include the following variables with the same exact name and the given data 
format before you run the SAS programs: 
AGEMOS Child's age in month. Numeric variable  
SEX Child's gender. Numeric variable. 1 for male and 2 for female. 
HEIGHT Child's recumbent length or standing height in centimeters. Numeric variable. 
RECUMBNT 
Indicator of child's height measurement. 1 for recumbent length and 0 for standing 
height (We use 1 for SKP). Numeric variable. 
WEIGHT Child's weight in kilograms. Numeric variable. 
HEADCIR 
Child's head circumference in centimeters (we did not collect so set to missing as 
.). 
Note 1: Use ‗.‘ for any missing information.  
Note 2: Avoid variable names starting with underscore "_" in your dataset, otherwise your data 
maybe replaced by some data from the SAS program. It should look like this:  
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3. Modify the gc-setup.sas program. 
Open the gc-setup.sas program using SAS PROGRAM EDITOR. Then modify the program 
using the following: 
%let datalib='x:\xxxxxx\'; 
Insert the subdirectory for your existing input dataset (e.g., 
'c:\project1\'). 
%let datain=xxxx; Insert the name of your existing input dataset (e.g., data1). 
%let dataout=xxxx; Insert the name of the file you wish to put the results into. If the 
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file name is the same as the input file name, the original file will 
be overwritten. All data from the input file will be placed in the 
output file, with the anthropometric indices (z-scores and 
percentiles) added to the end of the record. 
%let saspgm='x:\xxxxxx\gc-
calculate-BIV.sas'; 
Insert the subdirectory where the downloaded program gc-
calculate-BIV.sas was saved (e.g., 'c:\growthcharts\gc-calculate-
BIV.sas'). 
It will look like this:  
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No changes are needed in the gc-calculate-BIV.sas program file. 
4. Run the modified gc-setup.sas program. 
Submit the modified gc-setup.sas program. The newly created SAS dataset will contain all the 
original variables as well as the following variables for percentiles and z-scores. 
HTPCT: percentile for length-for-age or stature-for-age 
HAZ: z-score for length-for-age or stature-for-age 
WTPCT: percentile for weight-for-age 
WAZ: z-score for weight-for-age 
WHPCT: percentile for weight-for-length or weight-for-stature 
WHZ: z-score for weight-for-length or weight-for-stature 
BMIPCT: percentile for body mass index-for-age 
BMIZ: z-score for body mass index-for-age 
BMI: 
calculated body mass index value 
[weight(kg)/height(m)2 ] 
HCPCT: percentile for head circumference-for-age 
HCZ: z-score for head circumference-for-age 
_BIVHT: 
outlier variable for height-for-age (0 – acceptable normal range; 1 – too low; 2 – too 
high) 
_BIVWT: outlier variable for weight-for-age (0 – acceptable normal range; 1 – too low; 2 – 
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too high) 
_BIVWHT: 
outlier variable for weight-for-height (0 – acceptable normal range; 1 – too low; 2 – 
too high) 
_BIVBMI: 
outlier variable for body mass index-for-age (0 – acceptable normal range; 1 – too 
low; 2 – too high) 
 
5. Pay attention to the order to the output. The IDs usually do not follow the original order. So 
sort before coping and pasting the information needed to the file location desired. 
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APPENDIX C    
LIST OF PRIMERS AND PRIMER CONDITIONS 
 
SNP: rs8057044 
NCBI assay ID: ss12370850 
Gene: FTO   
Chromosome: 16  
SAS name: rs8057044  
Variation type: A/G  
Template primers: 
Orientation Symbol Sequence Tm 
Forward P1 CTT GTG GAA CCT TTG CCA AT 
 
54 
Reverse P2 CCT GGG CTA ACA GCA ATC TC 
 
56 
 
PCR product: 197 bp 
SNP primer: 
Strand Symbol Sequence Tm 
 P3 GGC TAA GTG AGG CAA CCT 
 
55 
    
 
Sequence:  
cttgtggaacctttgccaatctactgcactatgccaattaggaagatttgagtagctaaaaattccaagagtggaataatagttttattagttatat
cttgaaggccaatttccttttttaccctggaacttaggctaagtgaggcaacct[a/g]gaggagaaaatttctctcctgtcctgagattgctgtta
gcccagg 
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PCR conditions (temp. and cycles):    
                95C                    2 min 
   35         95C                    30 sec 
 cycles     60C                    30 sec   
                72C                   1.5 min  
            Repeat 34 cycles 
                72C                    5 min 
     Hold 4C 
PCR mix:  
QIAGEN Mix (3.5mM MgCl2) Per reaction (µl) 50 reactions (µl) 
Qiagen PCR buffer (10X, 15mM MgCl2) 1.2 60 
MgCl2(25mM) 0.96 48 
dNTPs (2.5mM each) 0.48 24 
F-primer (10µM)    0.144 7.2 
R-primer (10µM)   0.144 7.2 
Taq (5U/µl) 0.048 2.4 
dH2O 3.024 151.2 
Total 6 300 
 
FP primer: P3 A/G 
FP cycles: 40 
Modifications to standard protocol: None 
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SNP: rs925946 
NCBI assay ID: ss16542176 
Gene: BDNF   
Chromosome: 11  
SAS name: rs925946  
Variation type: G/T  
Template primers: 
Orientation Symbol Sequence Tm 
Forward P1 CTT GAA TGC CTT TTT GAC TC 
 
49.7 
Reverse P2 TGA CAA TAA TGA ACA TGA AAA CA 49.0 
 
PCR product: 252 bp 
SNP primer: 
Strand Symbol Sequence Tm 
 P3 TTA CAC CTG CAT AGT CAA CAG TGA 
 
56.0 
 P4 CAG GAG AGA CAG AAA TGC TGT CTT TA 56.5 
 
Sequence: 
cttgaatgcc tttttgactc gtttgagggt tccaatactg tgtgtgccaa cttagaccat tatttcccag aaacattcct cttagtctat 
cgatttcatt cccttgcaat gcactggccttacacctgc atagtcaaca gtga[g/t]taaag acagcatttc tgtctctcct 
gccacatcgg tacatttgtg tataggtagg tgttgctatt tgtgtaacgt attacgaagt gttttcatgt tcattattgt ca 
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PCR conditions (temp. and cycles):    
                95C                    2 min 
   35         95C                    30 sec 
 cycles     60C                    30 sec   
                72C                   1.5 min 
            Repeat 34 cycles 
                72C                    5 min 
     Hold 4C 
PCR mix: 
QIAGEN Mix (3.5mM MgCl2) Per reaction (µl) 50 reactions (µl) 
Qiagen PCR buffer (10X, 15mM MgCl2) 1.2 60 
MgCl2(25mM) 0.96 48 
dNTPs (2.5mM each) 0.48 24 
F-primer (10µM)    0.144 7.2 
R-primer (10µM)   0.144 7.2 
Taq (5U/µl) 0.048 2.4 
dH2O 3.024 151.2 
Total 6 300 
 
FP primer: P3 U/G 
FP cycles: 30 
Modifications to standard protocol: None 
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SNP: rs1137101 
NCBI assay ID: ss43851459 
Gene: LEPR   
Chromosome: 1  
SAS name: rs1137101   
Variation type: A/G  
Template primers: 
Orientation Symbol Sequence Tm 
Forward P1 TCA TGA ATG TTG TGA ATG TCT T 50.5 
Reverse P2 TCA TTA CAG TGT TAA GCA AAG TG 51.4 
 
PCR product: 250 bp 
SNP primer: 
Strand Symbol Sequence Tm 
 P3 AAA TCA CAT CTG GTG GAG TAA TTT TCC 55.6 
 P4 GGC TGA ACT GAC ATT AGA GGT GAC 57.3 
 
Sequence: 
tcatgaatgt tgtgaatgtc ttgtgcctgt gccaacagcc aaactcaacg acactctcct tatgtgtttg aaaatcacat ctggtggagt 
aattttcc[a/g]gtcacctctaa tgtcagttca gcccataaat atgggtaagt tatgcactaa aatgatgata ataggtctaa 
acatcagtca tatataaagg ttaaaaattg cttacaaaaa tatttgctag cttatctcac tttgcttaac actgtaatga 
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PCR conditions (temp. and cycles):    
                95C                    2 min 
   35         95C                    30 sec 
 cycles     60C                    30 sec   
                72C                   1.5 min 
            Repeat 34 cycles 
                72C                    5 min 
     Hold 4C 
PCR mix: 
QIAGEN Mix (3.5mM MgCl2) Per reaction (µl) 50 reactions (µl) 
Qiagen PCR buffer (10X, 15mM MgCl2) 1.2 60 
MgCl2(25mM) 0.96 48 
dNTPs (2.5mM each) 0.48 24 
F-primer (10µM)    0.144 7.2 
R-primer (10µM)   0.144 7.2 
Taq (5U/µl) 0.048 2.4 
dH2O 3.024 151.2 
Total 6 300 
 
FP primer: P3 A/G 
FP cycles: 35 
Modifications to standard protocol: None 
 
93 
 
SNP: rs6235 
NCBI assay ID: ss76891327 
Gene: PCSK1   
Chromosome: 5  
SAS name: rs6235   
Variation type: C/G  
Template primers: 
Orientation Symbol Sequence Tm 
Forward
 P1 
Reverse
 P2 
P1 
P2 
CGT CTC TGT GCT TGT AAG GTT TAG T 
 
56.7 
 
Reverse P2 AAA GTG CTT TCA GTA AAA ACT CAC C 
 
54.3 
 
 
PCR product: 201 bp 
SNP primer: 
Strand Symbol Sequence Tm 
 P3 CAA TCA CCA AAG AAG TCC CCA A 
 
55.4 
 
 P4 ATA AGG GAT GTT GAG CTT TGC A 
 
54.8 
 
 
Sequence: 
cgtctctgtg cttgtaaggt ttagtgttat aaaaaacatc aacatagtca ttatacagac tgtcttcaga gtctttaagc tgggaaggtt 
tgttcagctt ttccagggct tcgtagaagt tttcataagg gatgttgagc tttgca[c/g]ttggggacttctt tggtgattgc tttggcggtg 
agtttttact gaaagcactt t 
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PCR conditions (temp. and cycles):    
                95C                    2 min 
   35         95C                    30 sec 
 cycles     60C                    30 sec   
                72C                   1.5 min 
            Repeat 34 cycles 
                72C                    5 min 
     Hold 4C 
PCR mix: 
QIAGEN Mix (3.5mM MgCl2) Per reaction (µl) 50 reactions (µl) 
Qiagen PCR buffer (10X, 15mM MgCl2) 1.2 60 
MgCl2(25mM) 0.96 48 
dNTPs (2.5mM each) 0.48 24 
F-primer (10µM)    0.144 7.2 
R-primer (10µM)   0.144 7.2 
Taq (5U/µl) 0.048 2.4 
dH2O 3.024 151.2 
Total 6 300 
 
FP primer: P4 C/G 
FP cycles: 35 
Modifications to standard protocol: None 
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SNP: rs934778 
NCBI assay ID: ss44347148  
Gene: POMC   
Chromosome: 2  
SAS name: rs934778   
Variation type: C/T  
Template primers: 
Orientation Symbol Sequence Tm 
Forward P1 TCA ACC TTG GTG TCC TCT CCT 57.8 
 
Reverse P2 GTG ACT GTA ACA TCT GGG CAT TT 
 
55.5 
 
 
PCR product: 170 bp 
SNP primer: 
Strand Symbol Sequence Tm 
 P3 CTG GCT GTG TAC TTG AAT AGA TCA C 
 
55.3 
 
 P4 TTC CCA TTG TAC CCT GCC 
 
54.8 
 
 
Sequence: 
tcaaccttgg tgtcctctcc tggctccaag ggacaggctg ttcccattgt accctgcc[a/g]g tgatctattc aagtacacag 
ccagaacttg gtggaccagg caattagatt aaagctccaa gttgaccata gcacatttag ctctgaaaaa tgcccagatg 
ttacagtcac 
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PCR conditions (temp. and cycles):    
                95C                    2 min 
   35         95C                    30 sec 
 cycles     60C                    30 sec   
                72C                   1.5 min 
            Repeat 34 cycles 
                72C                    5 min 
     Hold 4C 
PCR mix: 
QIAGEN Mix (3.5mM MgCl2) Per reaction (µl) 50 reactions(µl) 
Qiagen PCR buffer (10X, 15mM MgCl2) 1.2 60 
dNTPs (2.5mM each) 0.48 24 
F-primer (10µM)   0.144 7.2 
R-primer (10µM)    0.144 7.2 
Taq (5U/µl) 0.048 2.4 
dH2O 3.984 199.2  
Total 6 300 
 
FP primer: P4 A/G 
FP cycles: 35 
Modifications to standard protocol: None 
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SNP: rs7799039 
NCBI assay ID: ss11884222  
Gene: LEP   
Chromosome: 7  
SAS name: rs7799039   
Variation type: A/G  
Template primers: 
Orientation Symbol Sequence Tm 
Forward P1 AAA GGC CTG GAG GAA TCA AT 
 
54.2 
 
Reverse P2 TTC CTG CAA CAT CTC AGC AC 
 
55.5 
 
 
PCR product: 319 bp 
SNP primer: 
Strand Symbol Sequence Tm 
 P3 TTG TTT TGC GAC AGG GTT GC 
 
56.9 
 
    
 
Sequence: 
aaaggcctgg aggaatcaat gtgcaatgta tgtgtgttcc ctggttcaag ggctgggaac tttctctaaa gggccaggta 
gaaaacattt taggctttct aagccaaggc aaaattgagg atattacatg ggtacttata caacaagaat aaacaattta cacaattttt 
tgttgacaga attcaaaact ttatagacac agaaatgcaa atttcctgta attttcccat gagaactatt cttcttttgt tttgttttgc 
gacagggttg c[a/g]ctgatcct cccgcctcag tctccctaag tgctgagatg ttgcaggaa 
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PCR conditions (temp. and cycles):    
                95C                    2 min 
   35         95C                    30 sec 
 cycles     60C                    30 sec   
                72C                   1.5 min 
            Repeat 34 cycles 
                72C                    5 min 
     Hold 4C 
PCR mix: 
QIAGEN Mix (3.5mM MgCl2) Per reaction (µl) 50 reactions(µl) 
Qiagen PCR buffer (10X, 15mM MgCl2) 1.2 60 
dNTPs (2.5mM each) 0.48 24 
F-primer (10µM)   0.144 7.2 
R-primer (10µM)    0.144 7.2 
Taq (5U/µl) 0.048 2.4 
dH2O 3.984 199.2  
Total 6 300 
 
FP primer: P3 A/G 
FP cycles: 40 
Modifications to standard protocol: None 
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SNP: rs2272382 
NCBI assay ID: ss97449069 
Gene: TUB   
Chromosome: 11   
SAS name: rs2272382   
Variation type: A/G  
Template primers: 
Orientation Symbol Sequence Tm 
Forward P1 CTG TTT TGC CTC CCT TTC CT 
 
55.3 
 
Reverse P2 GCT TCT TCT TCT GCT TCT GCT C 
 
56.0 
 
 
PCR product: 182 bp 
SNP primer: 
Strand Symbol Sequence Tm 
 P3 AGT TAT CGG GGG GTC CAC 
 
56.5 
 
    
 
Sequence: 
ctgttttgcc tccctttcct ggaccccaag tgttggggtg ccaaggacat ggggccttgg cccaaggtgg gctgtggacc 
ccccgataac gggctcccagttatcggggggtccac[a/g]gcccaccttgggccaaggccccatgcatagcg ggccctgctg 
gagcagaagc agaagaagaa 
gc 
 
 
 
100 
 
PCR conditions (temp. and cycles):    
                95C                    2 min 
   35         95C                    30 sec 
 cycles     62C                    30 sec   
                72C                   1.5 min 
            Repeat 34 cycles 
                72C                    5 min 
     Hold 4C 
PCR mix: 
QIAGEN Mix (3.5mM MgCl2) Per reaction (µl) 50 reactions(µl) 
Qiagen PCR buffer (10X, 15mM MgCl2) 1.2 60 
dNTPs (2.5mM each) 0.48 24 
F-primer (10µM)   0.144 7.2 
R-primer (10µM)    0.144 7.2 
Taq (5U/µl) 0.048 2.4 
dH2O 3.984 199.2  
Total 6 300 
 
FP primer: P3 A/G 
FP cycles: 30 
Modifications to standard protocol: None 
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APPENDIX D 
CLUSTERS AND QUESTIONS REGARDING THE SATIETY AND APPETITE 
CONTROL 
 
CFPQ SECTION 8 
The CFPQ scale in Section 8 is adapted from Musher-Eizenman‘s study (1).  A 5-point response 
scale ‗‗never, sometimes, always‘‘ were used in all the items in the survey.  
CFPQ SUBSCALES 
*Subsections we are interested in.  
Child Control—Parents allow the child control of his/her eating behaviors and parent–child 
feeding interactions. 
(5 items question 5, 6, 10, 11, and 12) alpha= 0.574 Mean = 2.46, SD = 0.63 
5. Do you let your child eat whatever s/he wants? 
6. At dinner, do you let this child choose the foods s/he wants from what is served? 
10. If this child does not like what is being served, do you make something else? 
11. Do you allow this child to eat snacks whenever s/he wants? 
12. Do you allow this child to leave the table when s/he is full, even if your family is not done 
eating? 
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*Emotion regulation—Parents use food to regulate the child‘s emotional states. 
(3 items question 7, 8, and 9) alpha = 0.729 Mean = 1.48 SD = 0.57 
7. When this child gets fussy, is giving him/her something to eat or drink the first thing you do? 
8. Do you give this child something to eat or drink if s/he is bored even if you think s/he is not 
hungry? 
9. Do you give this child something to eat or drink if s/he is upset even if you think s/he is not 
hungry? 
 
Encourage balance and variety—Parents promote well-balanced food intake, including the 
consumption of varied foods and healthy food choices. 
(4 items question 13, 24, 26, 38) alpha = 0.738 Mean = 4.3, SD = 0.6 
13. Do you encourage this child to eat healthy foods before unhealthy ones? 
24. I encourage my child to try new foods. 
26. I tell my child that healthy food tastes good. 
38. I encourage my child to eat a variety of foods. 
 
Environment—Parents make healthy foods available in the home. 
(4 items, question 14, 22, 16Reverse, 37Reverse) alpha = 0.666 Mean = 3.85, SD = 0.6 
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14. Most of the food I keep in the house is healthy. 
16. I keep a lot of snack food (potato chips, Doritos, cheese puffs) in my house. R 
22. A variety of healthy foods are available to my child at each meal served at home. 
37. I keep a lot of sweets (candy, ice cream, cake, pies, pastries) in my house. R 
 
*Food as reward—Parents use food as a reward for child behavior. 
(3 items question 23, 36 and 19) alpha = 0.706 Mean = 2.11, SD = 0.814 
23. I offer sweets (candy, ice cream, cake, pastries) to my child as a reward for good behavior. 
36. I withhold sweets/dessert from my child in response to bad behavior. 
19. I offer my child his/her favorite foods in exchange for good behavior. 
 
Involvement—Parents encourage child‘s involvement in meal planning and preparation. 
(3 items question 15, 20 and 32) alpha = 0.750 Mean = 2.87, SD = 0.94 
15. I involve my child in planning family meals. 
20. I allow my child to help prepare family meals. 
32. I encourage my child to participate in grocery shopping. 
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Modeling—Parents actively demonstrate healthy eating for the child. 
(4 items question 44, 46, 47 and 48) alpha = 0.866 Mean = 3.69, SD = 0.867 
44. I model healthy eating for my child by eating healthy foods myself. 
46. I try to eat healthy foods in front of my child, even if they are not my favorite. 
47. I try to show enthusiasm about eating healthy foods. 
48. I show my child how much I enjoy eating healthy foods. 
 
Monitoring—Parents keep track of child‘s intake of less healthy foods. 
(4 items, question 1, 2, 3, and 4) Cronbach's alpha = 0.893 Mean = 4.14, SD = 0.93 
1. How much do you keep track of the sweets (candy, ice cream, cake, pies, pastries) that your 
child eats? 
2. How much do you keep track of the snack food (potato chips, Doritos, cheese puffs) that your 
child eats? 
3. How much do you keep track of the high-fat foods that your child eats? 
4. How much do you keep track of the sugary drinks (soda/pop, kool-aid) this child drinks? 
 
Pressure—Parents pressure the child to consume more food at meals. 
(4 items question 17, 30, 39 and 49) alpha = 0.690 Mean = 2.51, SD = 0.79 
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17. My child should always eat all of the food on his/her plate. 
30. If my child says, ‗‗I‘m not hungry,‘‘ I try to get him/her to eat anyway. 
39. If my child eats only a small helping, I try to get him/her to eat more. 
49. When he/she says he/she is finished eating, I try to get my child to eat one more (two more, 
etc.) bites of food. 
 
* Restriction for Health—Parents control the child‘s food intake with the purpose of limiting less 
healthy foods and sweets. 
(4 items question 21, 28, 40, and 43) alpha = 0.75, Mean = 2.759, SD = 0.894 
21. If I did not guide or regulate my child‘s eating, s/he would eat too much of his/her favorite 
foods. 
28. If I did not guide or regulate my child‘s eating, he/she would eat too many junk foods. 
40. I have to be sure that my child does not eat too much of his/her favorite foods. 
43. I have to be sure that my child does not eat too many sweets (candy, ice cream, cake, or 
pastries). 
 
*Restriction for weight control—Parents control the child‘s food intake with the purpose of 
decreasing or maintaining the child‘s weight. 
(8 items question 18, 27, 29, 33, 34, 35, 41 and 45) alpha = 0.716, mean =1.62, SD = 0.49 
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18. I have to be sure that my child does not eat too many high-fat foods. 
27. I encourage my child to eat less so he/she won‘t get fat. 
29. I give my child small helpings at meals to control his/her weight. 
33. If my child eats more than usual at one meal, I try to restrict his/her eating at the next meal. 
34. I restrict the food my child eats that might make him/her fat. 
35. There are certain foods my child shouldn‘t eat because they will make him/her fat. 
41. I don‘t allow my child to eat between meals because I don‘t want him/her to get fat. 
45. I often put my child on a diet to control his/her weight. 
 
Teaching about nutrition—Parents use explicit didactic techniques to encourage the consumption 
of healthy foods. 
(3 items question 25, 31, and 42Reverse) alpha = 0.658, mean = 2.52, SD = 0.94 
25. I discuss with my child why it‘s important to eat healthy foods. 
31. I discuss with my child the nutritional value of foods. 
42. I tell my child what to eat and what not to eat without explanation.  
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